⌘K
Fundamental leadership · SEC EDGAR · no analyst estimates · as of 2026-09-10
Which industries lead on earnings and sales, today. As of 2026-09-10, 4,465 companies clear the eligibility gates and 1,340 rank Leader or Strong on filed EPS and revenue growth. The strongest industry group is Precious Metals with 29 Leader or Strong names. 19.9% of eligible companies also sit in the top relative-strength quintile — fundamentals and price agreeing.
Sector
| Ticker | Company | Rank | Δ3wk | Verdict | EPS YoY | Sales YoY | Margin Δ | 6M RS | Filed |
|---|---|---|---|---|---|---|---|---|---|
| HCWB | HCW Biologics Inc. Common Stock | 99 | ±0 | Leader | loss widened 71% | >+999% | — | 23 | 2026-08-14 |
| LQDA | Liquidia Corporation Common StockHuman Therapeutics | 99 | ±0 | Leader | to profit↑ | >+999% | >+10,000 bps | 94 | 2026-08-12 |
| ORMP | Oramed Pharmaceuticals Inc. | 99 | ±0 | Leader | +494% | — | — | 87 | 2026-08-10 |
| QTTB | Q32 Bio Inc. Common Stock | 99 | ±0 | Leader | loss narrowed 44% | — | — | 92 | 2026-08-05 |
| SLGL | Sol-Gel Technologies Ltd. Ordinary Shares | 99 | ±0 | Leader | >+999% | +218% | — | 19 | 2026-03-19 |
| ABUS | Arbutus Biopharma Corporation Common Stock | 98 | ±0 | Leader | to loss | -91% | >+10,000 bps | 61 | 2026-08-12 |
| BLLN | BillionToOne, Inc. Class A Common Stock | 98 | ±0 | Leader | to profit↑ | +64%↓ | — | 90 | 2026-08-05 |
| CGEN | Compugen Ltd | 98 | ±0 | Leader | to profit | +161% | +9649 bps | 61 | 2026-03-02 |
| LKFT | Lakefront Biotherapeutics American Depositary Shares | 98 | ±0 | Leader | +335% | +304% | +9485 bps | — | 2026-03-26 |
| MGTX | MeiraGTx Holdings plc Ordinary Shares | 98 | ±0 | Leader | to profit | >+999% | >+10,000 bps | 93 | 2026-08-13 |
| NIVF | NewGenIvf Group Limited Class A ordinary shares | 98 | -1 | Leader | to profit | >+999% | — | 2 | 2026-03-31 |
| PTGX | Protagonist Therapeutics, Inc | 98 | ±0 | Leader33 | to profit↑ | >+999%↑ | +923 bps | 91 | 2026-08-05 |
| ZVRA | Zevra Therapeutics, Inc. Common Stock | 98 | ±0 | Leader | -88% | +53%↓ | >+10,000 bps | 70 | 2026-08-05 |
| ATNM | Actinium Pharmaceuticals, Inc | 97 | ±0 | Leader | to profit↑ | — | — | 64 | 2026-08-07 |
| BCRX | BioCryst Pharmaceuticals Inc | 97 | ±0 | Leader | >+999% | +34% | -4301 bps | 46 | 2026-08-05 |
| ETON | Eton Pharmaceutcials, Inc. Common Stock | 97 | ±0 | Leader | to profit | +99% | +1683 bps | 99 | 2026-08-13 |
| IRWD | Ironwood Pharmaceuticals, Inc. - Class A | 97 | ±0 | Leader | +121% | +33% | +3638 bps | 61 | 2026-08-06 |
| NBIX | Neurocrine Biosciences IncHuman Therapeutics | 97 | ±0 | Leader | +31% | +39% | +384 bps | 75 | 2026-07-31 |
| PLX | Protalix BioTherapeutics, Inc. Common Stock | 97 | -1 | Leader | to profit | +27% | +1561 bps | 42 | 2026-08-12 |
| RADX | Radiopharm Theranostics Limited American Depositary Shares | 97 | ±0 | Leader | loss narrowed 86% | >+999% | — | 8 | 2025-09-18 |
| TER | Teradyne, Inc. Common StockRobotics & Autonomous SystemsSemiconductors & Equipment | 97 | ±0 | Leader33 | +386%↑ | +104%↑ | +1194 bps | 77 | 2026-07-31 |
| TGTX | TG Therapeutics, Inc.Human Therapeutics | 97 | ±0 | Leader | -71% | +70% | -186 bps | 96 | 2026-08-05 |
| ANAB | AnaptysBio, Inc. Common Stock | 96 | -1 | Leader | loss widened 44% | -8%↓ | >+10,000 bps | 31 | 2026-05-12 |
| ARQT | Arcutis Biotherapeutics, Inc. Common StockHuman Therapeutics | 96 | ±0 | Leader | to profit | +59%↓ | +4050 bps | 46 | 2026-08-05 |
| ARVN | Arvinas, Inc | 96 | ±0 | Leader | to profit | >+999% | +2607 bps | 15 | 2026-08-04 |
| CDNA | CareDx, Inc. | 96 | ±0 | Leader33 | to profit↑ | +52%↑ | +1196 bps | 98 | 2026-07-30 |
| ECVT | Ecovyst Inc. | 96 | ±0 | Leader | +40% | +42% | -102 bps | 37 | 2026-08-06 |
| FENC | Fennec Pharmaceuticals Inc. Common Stock | 96 | ±0 | Leader | to profit↑ | +85% | +2716 bps | 88 | 2026-08-13 |
| FF | Future Fuel Corporation | 96 | ±0 | Leader | to profit↑ | +121%↑ | -145 bps | 74 | 2026-08-10 |
| FTK | Flotek Industries, Inc. | 96 | ±0 | Leader | +420%↑ | +70% | +534 bps | 92 | 2026-08-06 |
| PODD | Insulet Corporation | 96 | ±0 | Leader | +328%↑ | +24% | -37 bps | 12 | 2026-08-05 |
| ALTO | Alto Ingredients, Inc. Common Stock | 95 | ±0 | Leader | to profit | +12%↑ | +989 bps | 32 | 2026-08-07 |
| ARGX | argenx SE American Depositary SharesHuman Therapeutics | 95 | ±0 | Leader | +53% | +89% | +2577 bps | 85 | 2026-03-19 |
| CAI | Caris Life Sciences, Inc. Common Stock | 95 | ±0 | Leader | to profit | +45%↓ | +5592 bps | 82 | 2026-08-05 |
| CRMD | CorMedix Inc. | 95 | ±0 | Leader | +4% | +157%↓ | — | 73 | 2026-08-13 |
| KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | 95 | ±0 | Leader | +145% | +56% | +1565 bps | 93 | 2026-07-28 |
| LGND | Ligand Pharmaceuticals Inc. | 95 | ±0 | Leader | +825% | +34% | +5087 bps | 83 | 2026-08-07 |
| OMDA | Omada Health, Inc. Common Stock | 95 | ±0 | Leader33 | to profit↑ | +43%↑ | +1526 bps | 92 | 2026-08-07 |
| SEPN | Septerna, Inc. Common Stock | 95 | ±0 | Leader | loss narrowed 48% | >+999%↑ | — | 89 | 2026-08-10 |
| SI | Shoulder Innovations, Inc. | 95 | ±0 | Leader | loss narrowed 100%↑ | +56%↓ | -965 bps | 86 | 2026-08-06 |
| BTSG | BrightSpring Health Services, Inc. Common Stock | 94 | ±0 | Leader | +192% | +23% | +115 bps | 87 | 2026-07-31 |
| COHR | Coherent Corp.AI Compute & Networking Hardware | 94 | ±0 | Leader | to profit | +34%↑ | +1029 bps | 71 | 2026-08-14 |
| EVAX | Evaxion A/S American Depositary Share | 94 | ±0 | Leader | loss narrowed 90% | +125% | — | 26 | 2026-03-05 |
| PMI | Picard Medical, Inc. | 94 | +11 | Leader | loss narrowed 93%↑ | +39%↓ | — | 2 | 2026-08-19 |
| PRTA | Prothena Corporation plc Ordinary Shares | 94 | -1 | Leader | loss narrowed 85% | -77% | >+10,000 bps | 41 | 2026-08-06 |
| RANI | Rani Therapeutics Holdings, Inc. Class A Common StockObesity & Weight-Loss Therapeutics | 94 | ±0 | Leader | loss narrowed 78%↓ | — | — | 13 | 2026-08-13 |
| VCYT | Veracyte, Inc.Genomics & Precision-Medicine Tools | 94 | ±0 | Leader | to profit | +15% | +1594 bps | 82 | 2026-07-31 |
| VIVS | VivoSim Labs, Inc. Common Stock | 94 | ±0 | Leader | — | — | — | 3 | 2026-08-12 |
| ALVO | Alvotech Ordinary Shares | 93 | ±0 | Leader | to profit | +20% | -88 bps | 88 | 2026-03-31 |
| ANIP | ANI Pharmaceuticals, Inc. | 93 | ±0 | Leader | +192% | +26% | +1334 bps | 41 | 2026-08-07 |
| CARL | Carlsmed, Inc. Common Stock | 93 | ±0 | Leader | loss narrowed 73%↓ | +57%↓ | +1423 bps | 80 | 2026-08-05 |
| CRON | Cronos Group Inc. Common Share | 93 | ±0 | Leader | to profit↑ | +58% | +4041 bps | 78 | 2026-08-06 |
| HTFL | Heartflow, Inc. Common Stock | 93 | -1 | Leader | loss narrowed 88%↓ | +48%↑ | +387 bps | 96 | 2026-08-13 |
| INNV | InnovAge Holding Corp. Common Stock | 93 | +58 | Leader | >+999% | +18%↑ | +375 bps | 78 | new filing |
| LFST | LifeStance Health Group, Inc. Common Stock | 93 | ±0 | Leader | to profit | +26%↑ | +497 bps | 96 | 2026-08-06 |
| LLY | Eli Lilly & Co.Obesity & Weight-Loss TherapeuticsHuman Therapeutics | 93 | ±0 | Leader | +26% | +48% | +1051 bps | 66 | 2026-08-05 |
| ONC | BeOne Medicines Ltd. American Depositary Shares | 93 | -1 | Leader | +167% | +30% | +1727 bps | 68 | 2026-08-05 |
| RCKT | Rocket Pharmaceuticals, Inc. Common Stock | 93 | ±0 | Leader | to profit | — | — | 19 | 2026-08-10 |
| VCEL | Vericel Corporation | 93 | ±0 | Leader | to profit↑ | +22% | +547 bps | 69 | 2026-07-30 |
| ADAG | Adagene Inc. American Depositary Shares | 92 | ±0 | Leader | loss narrowed 49% | >+999% | — | 40 | 2026-04-01 |
| ALB | Albemarle CorporationLithium Producers & Developers | 92 | ±0 | Leader | to profit↑ | +31% | +2504 bps | 20 | 2026-08-05 |
| ALNY | Alnylam Pharmaceuticals, Inc.Human Therapeutics | 92 | ±0 | Leader | — | +67%↓ | — | 23 | 2026-07-30 |
| LNZA | LanzaTech Global, Inc. Common Stock | 92 | ±0 | Leader | to profit↑ | -1%↓ | >+10,000 bps | 16 | 2026-08-14 |
| LXU | LSB INDUSTRIES INC | 92 | ±0 | Leader | to loss | +11%↓ | +1254 bps | 32 | 2026-07-30 |
| OMER | Omeros Corporation | 92 | ±0 | Leader | to profit↓ | — | — | 92 | 2026-08-12 |
| PHAT | Phathom Pharmaceuticals, Inc. Common Stock | 92 | ±0 | Leader | loss narrowed 80% | +88% | >+10,000 bps | 22 | 2026-07-30 |
| AGEN | Agenus Inc. | 91 | ±0 | Leader | loss narrowed 99% | +34% | >+10,000 bps | 97 | 2026-08-07 |
| BMEA | Biomea Fusion, Inc. Common Stock | 91 | ±0 | Leader | loss narrowed 76%↓ | — | — | 67 | 2026-08-05 |
| EDIT | Editas Medicine, Inc. Common Stock | 91 | ±0 | Leader | loss narrowed 76% | +232% | >+10,000 bps | 48 | 2026-08-05 |
| IMCR | Immunocore Holdings plc American Depositary SharesHuman Therapeutics | 91 | ±0 | Leader | loss narrowed 90% | +18% | +780 bps | 54 | 2026-08-06 |
| NEPH | Nephros Inc. | 91 | -1 | Leader | +450% | +36% | -9 bps | 69 | 2026-08-10 |
| SNWV | SANUWAVE Health, Inc. Common Stock | 91 | ±0 | Leader | loss widened 100%↓ | -3%↓ | -1331 bps | 3 | 2026-08-06 |
| URGN | UroGen Pharma Ltd. Ordinary SharesHuman Therapeutics | 91 | ±0 | Leader33 | loss narrowed 73%↑ | +199%↑ | +9580 bps | 97 | 2026-08-05 |
| ATHE | Alterity Therapeutics Limited American Depositary Shares | 90 | ±0 | Leader | loss narrowed 63% | +89% | — | 69 | 2026-08-28 |
| INDV | Indivior Pharmaceuticals, Inc. Common Stock | 90 | ±0 | Leader | +600% | +14%↓ | +1347 bps | 57 | 2026-08-03 |
| INSM | Insmed, Inc.Human Therapeutics | 90 | ±0 | Leader33 | loss narrowed 96%↑ | +296%↑ | >+10,000 bps | 38 | 2026-08-06 |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | 90 | ±0 | Leader | — | — | — | 59 | 2026-07-14 |
| PRVA | Privia Health Group, Inc. Common Stock | 90 | ±0 | Leader | +250% | +21% | +87 bps | 39 | 2026-08-06 |
| ALT | Altimmune, Inc. Common StockObesity & Weight-Loss Therapeutics | 89 | -1 | Leader | loss narrowed 56%↑ | +420% | — | 32 | 2026-08-12 |
| CRSP | CRISPR Therapeutics AGHuman Therapeutics | 89 | ±0 | Strong | loss narrowed 61%↑ | >+999%↑ | <-10,000 bps | 56 | 2026-08-03 |
| IOVA | Iovance Biotherapeutics, Inc. Common StockHuman Therapeutics | 89 | ±0 | Strong33 | loss narrowed 67%↑ | +66%↑ | +7730 bps | 94 | 2026-08-06 |
| MGNX | MacroGenics, Inc. | 89 | ±0 | Strong | to profit↑ | +48%↓ | +2285 bps | 73 | 2026-08-14 |
| NUVB | Nuvation Bio Inc. | 89 | ±0 | Leader | loss widened 6% | +556% | >+10,000 bps | 86 | 2026-08-06 |
| PALI | Palisade Bio, Inc. Common Stock | 89 | -1 | Leader | loss narrowed 91% | — | — | 50 | 2026-08-10 |
| PPG | PPG Industries, Inc. | 89 | ±0 | Leader | +4% | +7% | +138 bps | 51 | 2026-07-29 |
| PRME | Prime Medicine, Inc. Common Stock | 89 | ±0 | Leader | loss narrowed 41%↑ | -62%↓ | — | 33 | 2026-08-06 |
| ABVC | ABVC BioPharma, Inc. Common Stock | 88 | -1 | Strong | loss narrowed 77%↑ | -9% | — | 18 | 2026-08-12 |
| AVAH | Aveanna Healthcare Holdings Inc. Common Stock | 88 | ±0 | Strong | +38% | +14%↓ | +312 bps | 96 | 2026-08-13 |
| KRYS | Krystal Biotech, Inc. Common StockHuman Therapeutics | 88 | ±0 | Strong | +39% | +24% | +615 bps | 85 | 2026-08-03 |
| RIGL | Rigel Pharmaceuticals Inc. (New) | 88 | ±0 | Strong | -73%↓ | -23%↓ | -759 bps | 94 | 2026-08-04 |
| SNOA | Sonoma Pharmaceuticals, Inc. Common Stock | 88 | -1 | Strong33 | loss narrowed 88%↑ | +60%↑ | +1794 bps | 12 | 2026-08-06 |
| TARS | Tarsus Pharmaceuticals, Inc. Common StockHuman Therapeutics | 88 | ±0 | Strong | loss narrowed 10% | +69%↓ | +2517 bps | 70 | 2026-08-06 |
| VIR | Vir Biotechnology, Inc. Common Stock | 88 | -1 | Strong | to profit | >+999% | >+10,000 bps | 60 | 2026-08-05 |
| VTGN | Vistagen Therapeutics, Inc. Common Stock | 88 | -1 | Strong | loss narrowed 36%↑ | +505% | — | 7 | 2026-08-14 |
| ALGS | Aligos Therapeutics, Inc. Common Stock | 87 | -1 | Strong | loss narrowed 91% | -100% | — | 19 | 2026-08-06 |
| ATRC | AtriCure, Inc. | 87 | -1 | Strong | to profit | +13% | +908 bps | 94 | 2026-07-27 |
| AUPH | Aurinia Pharmaceuticals Inc | 87 | ±0 | Strong | +75% | +19%↓ | +2840 bps | 62 | 2026-08-06 |
| AVR | Anteris Technologies Global Corp. Common Stock | 87 | ±0 | Strong | loss narrowed 48% | +63%↑ | — | 78 | 2026-08-11 |
| GTBP | GT Biopharma Inc. Common Stock | 87 | ±0 | Strong | loss narrowed 99% | — | — | 12 | 2026-08-14 |
| ICCC | Immucell Corp | 87 | ±0 | Strong | +233%↑ | +12% | +647 bps | 90 | 2026-08-13 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 87 | ±0 | Strong | to profit | +16% | +2662 bps | 82 | 2026-08-03 |
| LUCD | Lucid Diagnostics Inc. Common Stock | 87 | ±0 | Strong | loss widened 0%↓ | +27% | — | 12 | 2026-08-12 |
| PACS | PACS Group, Inc. | 87 | ±0 | Strong | +52% | +9%↓ | +275 bps | 83 | 2026-08-04 |
| PHAR | Pharming Group N.V. ADS, each representing 10 ordinary shares | 87 | ±0 | Strong | to profit | +27% | +977 bps | 17 | 2026-04-02 |
| QUCY | Quantum Cyber N.V. Ordinary Shares | 87 | ±0 | Strong | loss narrowed 48%↓ | +141%↑ | — | — | 2026-08-14 |
| SINT | SiNtx Technologies, Inc. Common Stock | 87 | ±0 | Strong | loss narrowed 18%↓ | +199%↑ | — | 15 | 2026-08-11 |
| ADMA | ADMA Biologics, Inc.Human Therapeutics | 86 | -1 | Strong | +14% | +2% | +1100 bps | 13 | 2026-08-05 |
| AGL | agilon health, inc. | 86 | -1 | Strong | to profit↑ | +7% | +121 bps | 99 | 2026-08-05 |
| IRTC | iRhythm Holdings, Inc. Common Stock | 86 | ±0 | Strong | loss narrowed 98% | +20%↓ | +1306 bps | 41 | 2026-08-06 |
| PTCT | PTC Therapeutics, Inc.Human Therapeutics | 86 | -1 | Strong | to profit | +102% | -2825 bps | 53 | 2026-07-30 |
| TLSI | TriSalus Life Sciences, Inc. Common Stock | 86 | ±0 | Strong | loss narrowed 41% | +2% | +1840 bps | 66 | 2026-08-06 |
| FBIO | Fortress Biotech, Inc. | 85 | ±0 | Strong | to loss | +19%↓ | >+10,000 bps | 25 | 2026-08-13 |
| HALO | Halozyme Therapeutics, Inc. | 85 | ±0 | Strong | +43%↑ | +48% | -2202 bps | 92 | 2026-08-06 |
| NRXS | Neuraxis, Inc. | 85 | -1 | Strong | loss narrowed 14% | +116%↑ | — | 34 | 2026-08-11 |
| PDEX | Pro-Dex Inc New | 85 | +13 | Strong33 | +161%↑ | +17%↑ | +70 bps | 83 | new filing |
| SNDX | Syndax Pharmaceuticals, Inc.Human Therapeutics | 85 | -1 | Strong | loss narrowed 34% | +92%↓ | >+10,000 bps | 23 | 2026-08-04 |
| SPAI | Safe Pro Group Inc. Common Stock | 85 | ±0 | Strong | loss widened 15% | >+999%↑ | — | 38 | 2026-08-14 |
| TMDX | TransMedics Group, Inc. Common Stock | 85 | ±0 | Strong | -55% | +21%↓ | -221 bps | 16 | 2026-08-04 |
| WRBY | Warby Parker Inc. | 85 | -1 | Strong | to profit | +10% | +237 bps | 43 | 2026-08-06 |
| YSG | Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | 85 | -1 | Strong | loss narrowed 89% | +27% | +1999 bps | 14 | 2026-04-29 |
| HOWL | Werewolf Therapeutics, Inc. Common Stock | 84 | ±0 | Strong | to profit | — | — | 72 | 2026-07-31 |
| MNOV | Medicinova, Inc. | 84 | ±0 | Strong | loss narrowed 29% | +241% | — | 77 | 2026-08-13 |
| NSPR | InspireMD, Inc. | 84 | -1 | Strong | loss narrowed 35% | 0% | — | 9 | 2026-08-14 |
| PNTG | The Pennant Group, Inc. Common Stock | 84 | ±0 | Strong | +25% | +36%↓ | +11 bps | 69 | 2026-08-05 |
| ROP | Roper Technologies, Inc. Common Stock | 84 | ±0 | Strong | +233%↑ | +9% | -9 bps | 64 | 2026-07-31 |
| TCMD | Tactile Systems Technology, Inc. | 84 | ±0 | Strong | +143%↑ | +9% | +370 bps | 26 | 2026-08-10 |
| WVE | Wave Life Sciences Ltd. Ordinary Shares | 84 | ±0 | Strong | loss widened 10% | -74% | — | 6 | 2026-07-30 |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | 83 | ±0 | Strong | +157% | +10% | +137 bps | 84 | 2026-08-06 |
| CAMP | CAMP4 Therapeutics Corporation Common Stock | 83 | ±0 | Strong | loss narrowed 6% | +19% | — | 24 | 2026-08-13 |
| HYPR | Hyperfine, Inc. Class A Common Stock | 83 | ±0 | Strong | loss narrowed 25% | +45%↓ | >+10,000 bps | 16 | 2026-08-06 |
| LIVN | LivaNova PLC Ordinary Shares | 83 | -1 | Strong | +286%↑ | +11% | -65 bps | 79 | 2026-08-05 |
| LNSR | LENSAR, Inc. Common Stock | 83 | ±0 | Strong | to profit↑ | +20% | +1337 bps | 18 | 2026-08-13 |
| ODD | ODDITY Tech Ltd. Class A Ordinary Shares | 83 | ±0 | Strong | +10% | +25% | -320 bps | 81 | 2026-03-17 |
| PRLD | Prelude Therapeutics Incorporated | 83 | ±0 | Strong | loss narrowed 66% | — | — | 77 | 2026-08-11 |
| SHC | Sotera Health Company Common Stock | 83 | ±0 | Strong | +533%↑ | +9% | +644 bps | 83 | 2026-08-06 |
| SNES | SenesTech, Inc. Common Stock | 83 | -1 | Strong | loss narrowed 60%↓ | +23%↑ | — | 8 | 2026-08-06 |
| BHST | BioHarvest Sciences Inc. Common Stock | 82 | ±0 | Strong | loss narrowed 25% | +37% | +1159 bps | 9 | 2026-03-31 |
| DXCM | DexCom, Inc. | 82 | ±0 | Strong | +42% | +13% | +694 bps | 81 | 2026-07-30 |
| ELMD | Electromed, Inc. | 82 | -1 | Strong | +46% | +12% | +372 bps | 65 | 2026-08-25 |
| KEYS | Keysight Technologies, Inc. | 82 | +6 | Strong | +109% | +37%↑ | +330 bps | 68 | 2026-09-02 |
| LUCY | Innovative Eyewear, Inc. Common Stock | 82 | ±0 | Strong | loss narrowed 61% | +74%↑ | — | 22 | 2026-08-14 |
| MKSI | MKS Inc. Common StockSemiconductors & Equipment | 82 | ±0 | Strong33 | +162%↑ | +28%↑ | +202 bps | 71 | 2026-08-06 |
| MOV | Movado Group, Inc. | 82 | -3 | Strong | +308%↓ | +5%↓ | +389 bps | 87 | 2026-08-26 |
| TLRY | Tilray Brands, Inc. Common Stock | 82 | ±0 | Strong | loss narrowed 70% | +25%↑ | >+10,000 bps | 12 | 2026-07-28 |
| WLKP | WESTLAKE CHEMICAL PARTNERS LP | 82 | ±0 | Strong | -4% | 0% | -202 bps | 44 | 2026-08-05 |
| DTIL | Precision BioSciences, Inc. Common Stock | 81 | ±0 | Strong | loss narrowed 41%↓ | -100% | — | 89 | 2026-08-06 |
| FHTX | Foghorn Therapeutics Inc. Common Stock | 81 | ±0 | Strong | loss narrowed 64%↑ | +113% | >+10,000 bps | 25 | 2026-08-06 |
| GPRE | Green Plains, Inc. | 81 | -1 | Strong | to profit↑ | -31% | >+10,000 bps | 46 | 2026-08-06 |
| HURC | Hurco Cos Inc | 81 | +24 | Strong | to profit↑ | +3% | +111 bps | 91 | new filing |
| INMB | INmune Bio Inc. Common stock | 81 | ±0 | Strong | loss narrowed 95% | — | — | 93 | 2026-08-06 |
| NATR | Nature's Sunshine Products Inc. | 81 | ±0 | Strong | -32%↓ | +2% | +156 bps | 11 | 2026-08-06 |
| NVMI | Nova Ltd. Ordinary SharesSemiconductors & Equipment | 81 | -1 | Strong | +38% | +31% | +89 bps | 30 | 2026-02-17 |
| OCS | Oculis Holding AG Ordinary shares | 81 | ±0 | Strong | loss narrowed 11% | +75% | — | 8 | 2026-03-04 |
| RNXT | RenovoRx, Inc. Common Stock | 81 | -1 | Strong | loss narrowed 25% | +115%↓ | — | 97 | 2026-08-13 |
| ABBV | ABBVIE INC.Human Therapeutics | 80 | -1 | Strong | +290% | +10% | — | 65 | 2026-08-03 |
| BEAM | Beam Therapeutics Inc. Common StockHuman Therapeutics | 80 | ±0 | Strong | loss widened 18%↓ | -94% | >+10,000 bps | 40 | 2026-08-04 |
| BSX | Boston Scientific Corp. | 80 | ±0 | Strong | +15% | +8%↓ | +276 bps | 14 | 2026-08-03 |
| CLIR | ClearSign Technologies Corporation Common Stock (DE) | 80 | ±0 | Strong | loss narrowed 27%↑ | +321% | — | 37 | 2026-08-14 |
| ELAN | Elanco Animal Health Incorporated Common Stock | 80 | ±0 | Strong | +450%↑ | +10% | -1653 bps | 45 | 2026-08-05 |
| EOLS | Evolus, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 56% | +21% | +963 bps | 90 | 2026-08-05 |
| ESTA | Establishment Labs Holdings Inc. | 80 | ±0 | Strong | loss narrowed 32%↓ | +32%↓ | +2780 bps | 61 | 2026-08-07 |
| GERN | Geron Corp | 80 | ±0 | Strong | loss widened 0% | +17%↓ | — | 28 | 2026-08-05 |
| KYMR | Kymera Therapeutics, Inc. Common StockHuman Therapeutics | 80 | ±0 | Strong33 | loss narrowed 35%↑ | +466%↑ | >+10,000 bps | 89 | 2026-08-05 |
| STTK | Shattuck Labs, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 50%↓ | — | — | 56 | 2026-08-11 |
| VVOS | Vivos Therapeutics, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 44%↑ | +35% | -901 bps | 2 | 2026-08-14 |
| ASMB | Assembly Biosciences, Inc | 79 | ±0 | Strong | loss narrowed 85% | +39% | >+10,000 bps | 56 | 2026-08-13 |
| AUTL | Autolus Therapeutics plc American Depositary Share | 79 | ±0 | Strong | loss narrowed 17%↑ | +118%↓ | >+10,000 bps | 79 | 2026-08-11 |
| CCM | Concord Medical Services Holding Limited | 79 | ±0 | Strong | loss narrowed 70% | +21% | +8451 bps | 69 | 2026-04-29 |
| CERS | Cerus Corp | 79 | ±0 | Strong | loss narrowed 67% | +10%↓ | — | 86 | 2026-07-30 |
| CGNX | Cognex CorpRobotics & Autonomous Systems | 79 | ±0 | Strong | +79% | +17% | +770 bps | 75 | 2026-08-06 |
| COLL | Collegium Pharmaceutical, Inc. Common Stock | 79 | -1 | Strong | to loss | +6%↓ | +113 bps | 15 | 2026-08-06 |
| DYAI | Dyadic International, Inc. | 79 | ±0 | Strong | loss widened 0% | -1% | — | 14 | 2026-08-12 |
| GMED | GLOBUS MEDICAL INC | 79 | ±0 | Strong | -26%↓ | +6% | +962 bps | 30 | 2026-08-06 |
| GRAL | GRAIL, Inc. Common Stock | 79 | ±0 | Strong | loss narrowed 19% | +26% | >+10,000 bps | 93 | 2026-08-06 |
| STAA | Staar Surgical Co | 79 | -1 | Strong | to profit↑ | +111% | +5287 bps | 84 | 2026-08-12 |
| STIM | Neuronetics, Inc. Common Stock | 79 | ±0 | Strong | loss narrowed 67% | +9% | +1970 bps | 98 | 2026-08-11 |
| STLN | Starling Oncology, Inc. Common Stock | 79 | — | Strong | loss narrowed 47% | +35%↓ | +661 bps | — | 2026-08-06 |
| VHI | Valhi, Inc. | 79 | ±0 | Strong | >+999%↑ | +12%↑ | -641 bps | 84 | 2026-08-06 |
| APYX | Apyx Medical Corporation Common Stock | 78 | ±0 | Strong | loss narrowed 22%↓ | +22%↓ | +2041 bps | 21 | 2026-08-06 |
| ARDX | Ardelyx, Inc. | 78 | ±0 | Strong | loss narrowed 12%↑ | +24% | +260 bps | 13 | 2026-08-06 |
| ATEC | Alphatec Holdings, Inc. | 78 | ±0 | Strong | loss narrowed 41%↑ | +15% | +1080 bps | 18 | 2026-08-04 |
| CBIO | Crescent Biopharma, Inc. Common Stock | 78 | -1 | Strong | loss narrowed 76%↑ | — | — | 93 | 2026-07-30 |
| COYA | Coya Therapeutics, Inc. Common Stock | 78 | ±0 | Strong | loss narrowed 22% | +49% | — | 38 | 2026-08-11 |
| DD | DuPont de Nemours, Inc. Common Stock | 78 | ±0 | Strong | +650%↑ | +4% | -158 bps | 39 | 2026-08-04 |
| HXL | Hexcel Corporation | 78 | ±0 | Strong | +276% | +8% | +428 bps | 59 | 2026-07-29 |
| HYFT | MindWalk Holdings Corp. Common Stock | 78 | ±0 | Strong | loss narrowed 88%↑ | -32% | — | 54 | 2026-07-23 |
| INVA | Innoviva, Inc. Common Stock | 78 | ±0 | Strong | to loss↓ | +19% | +407 bps | 39 | 2026-08-05 |
| NTRA | Natera, Inc. Common StockGenomics & Precision-Medicine Tools | 78 | ±0 | Strong | loss narrowed 36% | +38%↓ | +425 bps | 93 | 2026-08-07 |
| PLRX | Pliant Therapeutics, Inc. Common Stock | 78 | -1 | Strong | loss narrowed 49% | — | — | 31 | 2026-08-11 |
| RNTX | Rein Therapeutics, Inc. Common Stock | 78 | ±0 | Strong | loss narrowed 64% | — | — | 14 | 2026-08-14 |
| AQST | Aquestive Therapeutics, Inc. Common Stock | 77 | ±0 | Strong | loss widened 29% | +38% | +2167 bps | 71 | 2026-08-11 |
| CDXS | Codexis, Inc. | 77 | ±0 | Strong | loss narrowed 19%↓ | -3% | +6453 bps | 67 | 2026-08-11 |
| DARE | Dare Bioscience, Inc. Common Stock | 77 | -1 | Strong | loss narrowed 56%↓ | — | — | 9 | 2026-08-13 |
| RFL | Rafael Holdings, Inc. Class B Common Stock | 77 | ±0 | Strong | loss narrowed 58% | -51% | — | 92 | 2026-06-11 |
| SIBN | SI-BONE, Inc. Common Stock | 77 | ±0 | Strong | loss narrowed 36% | +15% | +660 bps | 83 | 2026-08-04 |
| VANI | Vivani Medical, Inc. Common Stock (DE) | 77 | -1 | Strong | loss narrowed 42%↑ | — | — | 63 | 2026-08-13 |
| BBIO | BridgeBio Pharma, Inc. Common Stock | 76 | ±0 | Strong | loss narrowed 18% | +120% | >+10,000 bps | 52 | 2026-08-10 |
| BVS | Bioventus Inc. Class A Common Stock | 76 | -1 | Strong | +327% | +4% | +376 bps | 90 | 2026-08-05 |
| CDIO | Cardio Diagnostics Holdings Inc. Common stock | 76 | -1 | Strong | loss narrowed 47%↑ | -28% | — | 8 | 2026-08-07 |
| DERM | Journey Medical Corporation Common Stock | 76 | ±0 | Strong | loss narrowed 94%↑ | +19%↓ | +788 bps | 32 | 2026-08-12 |
| FDMT | 4D Molecular Therapeutics, Inc. Common Stock | 76 | ±0 | Strong | loss widened 6% | >+999% | — | 92 | 2026-08-13 |
| GOSS | Gossamer Bio, Inc. Common Stock | 76 | -1 | Strong | loss narrowed 53%↑ | -20% | +5021 bps | 5 | 2026-08-13 |
| ISRG | Intuitive Surgical Inc.Robotics & Autonomous Systems | 76 | -1 | Strong | +27%↑ | +19% | +248 bps | 21 | 2026-07-21 |
| LNTH | Lantheus Holdings, Inc | 76 | ±0 | Strong | -1%↓ | +3% | -935 bps | 76 | 2026-08-06 |
| NL | NLI Holdings, Inc. | 76 | ±0 | Strong | >+999%↑ | +8%↑ | -1804 bps | 74 | 2026-08-05 |
| SRTA | Strata Critical Medical, Inc. Class A Common Stock | 76 | ±0 | Strong | loss widened 140% | +2% | +102 bps | 62 | 2026-08-04 |
| ALLO | Allogene Therapeutics, Inc. Common Stock | 75 | -1 | Strong | loss narrowed 43% | — | — | 16 | 2026-08-12 |
| ATYR | aTyr Pharma, Inc. Common Stock | 75 | -1 | Strong | loss narrowed 50%↑ | — | — | 9 | 2026-08-07 |
| BFLY | Butterfly Network, Inc. | 75 | -1 | Strong | loss narrowed 17% | +39% | +819 bps | 95 | 2026-07-30 |
| BFRI | Biofrontera Inc. Common Stock | 75 | ±0 | Strong | loss narrowed 91%↑ | +33% | +2737 bps | 94 | 2026-08-13 |
| ECOR | electroCore, Inc. Common Stock | 75 | ±0 | Strong | loss narrowed 25% | +28% | +947 bps | 89 | 2026-08-06 |
| INFU | InfuSystem Holdings, Inc. | 75 | ±0 | Strong | +25% | +3% | +191 bps | 80 | 2026-08-04 |
| MYO | Myomo Inc. | 75 | -1 | Strong | loss narrowed 18%↑ | +21%↑ | -420 bps | 95 | 2026-08-05 |
| QGEN | QIAGEN N.V. | 75 | ±0 | Strong | +424% | +6% | +1735 bps | 53 | 2026-03-20 |
| RPRX | Royalty Pharma plc Class A Ordinary Shares | 75 | -1 | Strong | -43% | +16%↑ | -2023 bps | 80 | 2026-08-05 |
| SNTI | Senti Biosciences Holdings, Inc. Common Stock | 75 | -1 | Strong | loss narrowed 27%↓ | — | — | 5 | 2026-08-14 |
| AVIR | Atea Pharmaceuticals, Inc. Common Stock | 74 | -1 | Strong | loss narrowed 3% | +622% | — | 31 | 2026-08-12 |
| AXSM | Axsome Therapeutics, Inc | 74 | ±0 | Strong | loss widened 2% | +46%↓ | +2229 bps | 84 | 2026-08-10 |
| CLLS | Cellectis S.A. American Depositary Shares | 74 | ±0 | Strong | loss narrowed 14% | +107% | — | 27 | 2026-03-20 |
| HRMY | Harmony Biosciences Holdings, Inc. Common Stock | 74 | -1 | Strong | +88%↑ | +30% | -469 bps | 88 | 2026-08-04 |
| INM | InMed Pharmaceuticals Inc. Common Shares | 74 | -2 | Strong | loss narrowed 86% | -26%↓ | — | 93 | new filing |
| INTT | inTEST Corporation | 74 | -1 | Strong33 | to profit↑ | +27%↑ | +132 bps | 23 | 2026-08-10 |
| NDRA | ENDRA Life Sciences Inc. Common Stock | 74 | -1 | Strong | to profit↑ | — | — | 94 | 2026-08-14 |
| RYTM | Rhythm Pharmaceuticals, Inc. Common StockHuman Therapeutics | 74 | ±0 | Strong | loss narrowed 3%↑ | +47% | +2991 bps | 67 | 2026-08-04 |
| AMTX | Aemetis, Inc. (DE) Common Stock | 73 | ±0 | Strong | loss narrowed 68% | +20% | +1424 bps | 84 | 2026-08-06 |
| BBNX | Beta Bionics, Inc. Common Stock | 73 | -1 | Strong | loss widened 36%↓ | +38%↓ | +1039 bps | 91 | 2026-07-29 |
| BCDA | BioCardia, Inc. Common Stock | 73 | ±0 | Strong | loss narrowed 68% | — | — | 31 | 2026-08-12 |
| CV | CapsoVision, Inc. Common Stock | 73 | ±0 | Strong | loss narrowed 93%↓ | +10%↑ | -3982 bps | 77 | 2026-08-13 |
| EXEL | Exelixis IncHuman Therapeutics | 73 | ±0 | Strong | +26%↓ | +11%↑ | +851 bps | 86 | 2026-08-05 |
| ITRI | Itron Inc | 73 | ±0 | Strong | -19%↓ | -7% | +136 bps | 52 | 2026-07-28 |
| JAGX | Jaguar Health, Inc. | 73 | -19 | Strong | loss widened 53%↓ | -59% | >+10,000 bps | 1 | 2026-08-19 |
| MDGL | Madrigal Pharmaceuticals, Inc. Common StockHuman Therapeutics | 73 | ±0 | Strong | loss widened 5% | +71%↓ | +3497 bps | 78 | 2026-07-30 |
| SLS | SELLAS Life Sciences Group, Inc. Common Stock | 73 | -1 | Strong | loss narrowed 29% | — | — | 98 | 2026-08-11 |
| THC | Tenet Healthcare Corporation New | 73 | -1 | Strong | +213%↑ | +7% | +304 bps | 66 | 2026-07-29 |
| UAN | CVR Partners, LP | 73 | ±0 | Strong | +100%↑ | +20% | +769 bps | 58 | 2026-07-29 |
| BLFS | BioLife Solutions Inc. | 72 | ±0 | Strong | to profit↑ | +12%↓ | — | 95 | 2026-08-06 |
| IMAX | Imax Corp | 72 | ±0 | Strong | +35% | +12% | +360 bps | 82 | 2026-07-23 |
| KTTA | Pasithea Therapeutics Corp. Common Stock | 72 | ±0 | Strong | loss narrowed 77% | >+999% | — | 15 | 2026-08-14 |
| LCTX | Lineage Cell Therapeutics, Inc. | 72 | -1 | Strong | loss narrowed 77%↑ | -61%↓ | >+10,000 bps | 14 | 2026-08-06 |
| MRKR | Marker Therapeutics, Inc. Common Stock | 72 | -1 | Strong | loss narrowed 69% | +115% | — | 33 | 2026-08-14 |
| ROG | Rogers Corporation | 72 | ±0 | Strong | to profit | +5%↑ | -574 bps | 80 | 2026-07-29 |
| SBC | SBC Medical Group Holdings Incorporated Common Stock | 72 | ±0 | Strong | +400% | +13%↑ | -2114 bps | 74 | 2026-08-13 |
| TNDM | Tandem Diabetes Care, Inc. | 72 | ±0 | Strong | loss narrowed 60% | +6%↑ | +1550 bps | 28 | 2026-08-06 |
| VRDN | Viridian Therapeutics, Inc. Common Stock | 72 | -1 | Strong | loss widened 21% | +279%↑ | — | 24 | 2026-08-06 |
| ACIU | AC Immune SA | 71 | ±0 | Strong | loss narrowed 9% | +90% | — | 34 | 2026-03-13 |
| ADGM | Adagio Medical Holdings, Inc Common Stock | 71 | -1 | Strong | loss narrowed 14% | — | — | 13 | 2026-08-11 |
| AGIO | Agios Pharmaceuticals, Inc. | 71 | ±0 | Strong33 | loss narrowed 12%↑ | +259%↑ | >+10,000 bps | 74 | 2026-07-30 |
| ENOV | Enovis Corporation | 71 | ±0 | Strong | loss narrowed 97%↑ | +3% | -1043 bps | 21 | 2026-08-06 |
| ENSG | The Ensign Group, Inc. | 71 | ±0 | Strong | +17% | +17%↓ | -1 bps | 27 | 2026-07-27 |
| GKOS | Glaukos Corporation | 71 | ±0 | Strong | loss narrowed 9%↑ | +50%↑ | -922 bps | 93 | 2026-07-29 |
| IXHL | Incannex Healthcare Limited American Depositary Shares | 71 | ±0 | Strong | loss widened 17% | +617% | — | 11 | 2026-05-15 |
| NRXP | NRX Pharmaceuticals, Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 55%↓ | — | — | 95 | 2026-08-14 |
| NVST | Envista Holdings Corporation Common stock, $0.01 par value per share | 71 | ±0 | Strong | +106%↓ | +7%↓ | +361 bps | 45 | 2026-08-05 |
| OTLK | Outlook Therapeutics, Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 73% | — | — | 91 | 2026-08-18 |
| QURE | uniQure N.V.Human Therapeutics | 71 | ±0 | Strong | loss widened 4% | +127% | <-10,000 bps | 98 | 2026-07-29 |
| SNDL | Sundial Growers Inc. Common Shares | 71 | ±0 | Strong | loss narrowed 83% | +3% | +1001 bps | 33 | 2026-03-12 |
| XGN | Exagen Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 38%↑ | +16% | +528 bps | 97 | 2026-08-04 |
| AZN | AstraZeneca PLCObesity & Weight-Loss TherapeuticsHuman Therapeutics | 70 | ±0 | Strong | +27% | +12% | — | 28 | 2026-02-24 |
| COHU | Cohu IncSemiconductors & Equipment | 70 | ±0 | Strong | to profit↑ | +38% | +1390 bps | 96 | 2026-07-31 |
| GANX | Gain Therapeutics, Inc. Common Stock | 70 | -1 | Strong | loss narrowed 42%↑ | — | — | 13 | 2026-08-11 |
| GRMN | Garmin Ltd | 70 | -1 | Strong | +22%↑ | +14% | +121 bps | 69 | 2026-07-29 |
| LMAT | LeMaitre Vascular, Inc. | 70 | ±0 | Strong | +23%↓ | +10%↓ | +612 bps | 20 | 2026-08-05 |
| NEGG | Newegg Commerce, Inc. Common Shares | 70 | ±0 | Strong | loss narrowed 89% | +17% | +351 bps | 6 | 2026-04-28 |
| NHC | National Healthcare Corp. | 70 | ±0 | Strong | +67% | +4% | +172 bps | 89 | 2026-08-06 |
| SBFM | Sunshine Biopharma Inc. | 70 | -1 | Strong | loss widened 40% | -2%↑ | +136 bps | 2 | 2026-08-13 |
| SGHT | Sight Sciences, Inc. Common Stock | 70 | -1 | Strong | loss narrowed 65% | +20%↑ | +3037 bps | 97 | 2026-08-05 |
| VMD | Viemed Healthcare, Inc. Common Shares | 70 | ±0 | Strong | -12%↓ | +24% | -117 bps | 44 | 2026-08-03 |
| CNTB | Connect Biopharma Holdings Limited Ordinary Shares | 69 | ±0 | Average | loss widened 17% | >+999% | — | 17 | 2026-08-12 |
| EYE | National Vision Holdings, Inc. Common Stock | 69 | -1 | Strong | +36% | +3%↓ | +364 bps | 15 | 2026-08-13 |
| GH | Guardant Health, Inc. Common StockGenomics & Precision-Medicine Tools | 69 | ±0 | Average | loss widened 12% | +44% | +1584 bps | 95 | 2026-07-30 |
| IFRX | InflaRx N.V. Common Stock | 69 | -1 | Strong | loss narrowed 13%↑ | +520% | — | 97 | 2026-03-20 |
| PAHC | Phibro Animal Health Corporation Class A | 69 | -21 | Average | +21% | +5%↓ | +428 bps | 21 | 2026-08-26 |
| PRQR | ProQR Therapeutics N.V. Ordinary Shares | 69 | ±0 | Average | loss narrowed 20%↑ | +9%↑ | <-10,000 bps | 60 | 2026-03-12 |
| SMTI | Sanara MedTech Inc. Common Stock | 69 | -1 | Strong | loss narrowed 78% | +9% | +1714 bps | 94 | 2026-08-11 |
| TECH | Bio-Techne Corp. | 69 | +30 | Average | to profit↑ | +1% | +1235 bps | 85 | 2026-08-24 |
| AXIL | AXIL Brands, Inc. | 68 | -1 | Average | — | — | — | 58 | 2026-08-18 |
| CF | CF Industries Holding, Inc. | 68 | ±0 | Average | +100% | +18%↓ | +1151 bps | 66 | 2026-08-06 |
| FTLF | FitLife Brands, Inc. Common Stock | 68 | ±0 | Average | +11% | +65% | -744 bps | 14 | 2026-08-13 |
| HCM | HUTCHMED (China) Limited American Depositary Shares | 68 | ±0 | Average | >+999% | -13% | -20 bps | 36 | 2026-03-05 |
| ABEO | Abeona Therapeutics Inc. Common Stock | 67 | -1 | Average | to loss | >+999% | — | 63 | 2026-08-13 |
| AVNT | Avient Corporation | 67 | -1 | Average | +23% | +6%↑ | +148 bps | 72 | 2026-08-06 |
| CODA | Coda Octopus Group, Inc. Common stock | 67 | -1 | Average | +88% | -2%↓ | +494 bps | 17 | 2026-06-15 |
| CYTK | Cytokinetics Inc.Human Therapeutics | 67 | ±0 | Average | loss widened 34%↓ | -57% | <-10,000 bps | 70 | 2026-08-06 |
| HURA | TuHURA Biosciences, Inc. Common Stock | 67 | -1 | Average | loss narrowed 33%↑ | — | — | 52 | 2026-08-14 |
| IVVD | Invivyd, Inc. Common Stock | 67 | ±0 | Average | loss widened 17%↓ | +21%↓ | +5285 bps | 8 | 2026-08-13 |
| PGNY | Progyny, Inc. Common Stock | 67 | ±0 | Average | +79%↑ | +5% | +237 bps | 92 | 2026-08-07 |
| SNN | Smith & Nephew plc | 67 | ±0 | Average | +52% | +6% | +157 bps | 28 | 2026-03-16 |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | 66 | -1 | Average | loss widened 47%↓ | +22%↓ | +4686 bps | 94 | 2026-08-04 |
| ANIK | Anika Therapeutics Inc | 66 | ±0 | Average | to profit | +16%↑ | — | 90 | 2026-07-29 |
| CHE | Chemed Corporation | 66 | ±0 | Average | +44%↑ | +9% | -438 bps | 81 | 2026-07-31 |
| CVRX | CVRx, Inc. Common Stock | 66 | ±0 | Average | loss narrowed 7%↑ | +16% | +1401 bps | 7 | 2026-08-06 |
| GDTC | CytoMed Therapeutics Limited Ordinary Shares | 66 | ±0 | Average | loss widened 55% | +367% | — | 23 | 2026-03-31 |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares)Human Therapeutics | 66 | ±0 | Average | +123% | +4% | +1147 bps | 33 | 2026-07-28 |
| HCSG | Healthcare Services Group | 66 | -1 | Average | to profit | +3%↓ | +724 bps | 62 | 2026-07-24 |
| PHG | KONINKLIJKE PHILIPS N.V. | 66 | -1 | Average | to profit | -1% | +516 bps | 34 | 2026-02-19 |
| PHIO | Phio Pharmaceuticals Corp. Common Stock | 66 | -1 | Average | loss narrowed 20% | — | — | 26 | 2026-08-06 |
| SCNX | Scienture Holdings, Inc. Common Stock | 66 | ±0 | Average | loss narrowed 85% | — | — | 23 | 2026-08-13 |
| SSII | SS Innovations International Inc. Common Stock | 66 | ±0 | Average | to loss | +39% | +2355 bps | 17 | 2026-08-13 |
| ALNT | Allient Inc. Common Stock | 65 | ±0 | Average | +79% | +10% | +198 bps | 88 | 2026-08-05 |
| MSA | Mine Safety Incorporated | 65 | ±0 | Average | +40%↑ | +6% | +84 bps | 47 | 2026-07-31 |
| SDGR | Schrodinger, Inc. Common Stock | 65 | -1 | Average | to profit | +8% | +2185 bps | 90 | 2026-08-05 |
| VRTX | Vertex Pharmaceuticals IncHuman Therapeutics | 65 | ±0 | Average | +8% | +12% | +359 bps | 56 | 2026-08-04 |
| WST | West Pharmaceutical Services, Inc. | 65 | -1 | Average | +18% | +14% | +80 bps | 89 | 2026-07-23 |
| ZBH | Zimmer Biomet Holdings, Inc. | 65 | -1 | Average | +34% | +5%↓ | -193 bps | 47 | 2026-08-05 |
| ADUS | Addus HomeCare Corp. | 64 | ±0 | Average | +24% | +8% | +91 bps | 69 | 2026-08-04 |
| CDRE | Cadre Holdings, Inc. | 64 | -1 | Average | -13% | +32%↑ | -94 bps | 27 | 2026-08-05 |
| ONTO | Onto Innovation Inc.Semiconductors & Equipment | 64 | ±0 | Average | +75% | +35%↑ | -88 bps | 87 | 2026-08-06 |
| STE | STERIS plc | 64 | ±0 | Average | +14% | +7% | +227 bps | 43 | 2026-08-07 |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 64 | -1 | Average | loss narrowed 37% | +578%↑ | — | 33 | 2026-08-10 |
| AMGN | Amgen IncObesity & Weight-Loss TherapeuticsHuman Therapeutics | 63 | ±0 | Average | +65% | +10% | +653 bps | 51 | 2026-08-05 |
| CON | Concentra Group Holdings Parent, Inc. | 63 | ±0 | Average | +46% | +10%↓ | +68 bps | 91 | 2026-08-06 |
| KPRX | Kiora Pharmaceuticals, Inc. Common Stock | 63 | ±0 | Average | loss narrowed 37%↑ | — | — | 73 | 2026-08-07 |
| MLSS | Milestone Scientific, Inc. Common Stock | 63 | ±0 | Average | loss narrowed 50% | +22% | — | 90 | 2026-08-13 |
| MMSI | Merit Medical Systems Inc | 63 | -1 | Average | +20%↓ | +10% | +147 bps | 78 | 2026-07-30 |
| NPCE | Neuropace, Inc. Common Stock | 63 | ±0 | Average | loss narrowed 31% | -3%↓ | +718 bps | 42 | 2026-08-11 |
| NTR | Nutrien Ltd. Common Shares | 63 | ±0 | Average | +243% | +4% | +675 bps | 48 | 2026-02-27 |
| QTRX | Quanterix Corporation Common Stock | 63 | -1 | Average | loss widened 35% | +34% | -2811 bps | 10 | 2026-08-10 |
| RARE | Ultragenyx Pharmaceutical Inc.Human Therapeutics | 63 | ±0 | Average | loss narrowed 23% | +29% | +914 bps | 15 | 2026-08-05 |
| RCUS | Arcus Biosciences, Inc. | 63 | ±0 | Average | to loss↓ | +313%↑ | — | 60 | 2026-08-05 |
| RLAY | Relay Therapeutics, Inc. Common Stock | 63 | ±0 | Average | loss widened 0%↓ | -48%↑ | — | 94 | 2026-08-06 |
| CSW | CSW Industrials, Inc. | 62 | ±0 | Average | +25%↑ | +33% | -323 bps | 62 | 2026-07-30 |
| DRIO | DarioHealth Corp. Common Stock | 62 | ±0 | Average | +372%↓ | -4%↑ | +424 bps | 21 | 2026-08-11 |
| DVA | DaVita Inc. | 62 | ±0 | Average | +56%↑ | +5%↓ | -59 bps | 71 | 2026-08-04 |
| FMS | Fresenius Medical Care AG | 62 | ±0 | Average | +414%↑ | -4% | +260 bps | 46 | 2026-02-24 |
| IDXX | Idexx Laboratories Inc | 62 | ±0 | Average | +18% | +10%↓ | +95 bps | 30 | 2026-08-04 |
| NNVC | NanoViricides Inc. | 62 | ±0 | Average | loss narrowed 36% | — | — | 34 | 2026-05-15 |
| PCRX | Pacira BioSciences, Inc. Common Stock | 62 | -1 | Average | to profit↑ | +6% | +1744 bps | 64 | 2026-08-04 |
| UHS | Universal Health Services, Inc. Class B | 62 | ±0 | Average | +10%↓ | +8% | +36 bps | 39 | 2026-08-07 |
| BIOA | BioAge Labs, Inc. Common StockObesity & Weight-Loss Therapeutics | 61 | ±0 | Average | loss narrowed 3%↑ | +2%↓ | — | 8 | 2026-08-05 |
| CGON | CG Oncology, Inc. Common stock | 61 | ±0 | Average | loss widened 67%↓ | — | — | 65 | 2026-08-06 |
| EHC | Encompass Health Corporation Common Stock | 61 | -1 | Average | +11% | +10% | +50 bps | 75 | 2026-08-07 |
| HYPD | Hyperion DeFi, Inc. Common Stock | 61 | ±0 | Average | to profit↑ | — | — | 59 | 2026-08-13 |
| MDT | Medtronic plc | 61 | +15 | Average33 | +41%↑ | +14%↑ | +18 bps | 54 | new filing |
| MRNA | Moderna, Inc. Common StockHuman Therapeutics | 61 | ±0 | Average | loss narrowed 8% | +2% | -4268 bps | 98 | 2026-07-31 |
| PRCT | PROCEPT BioRobotics Corporation Common Stock | 61 | ±0 | Average | loss widened 34% | +19% | -49 bps | 20 | 2026-08-05 |
| BMY | Bristol-Myers Squibb Co.Human Therapeutics | 60 | -1 | Average | +153% | +6%↑ | +1039 bps | 59 | 2026-07-30 |
| CE | Celanese Corporation Common Stock | 60 | -1 | Average | -38% | +9%↑ | +43 bps | 34 | 2026-08-05 |
| COO | The Cooper Companies, Inc. Common Stock | 60 | +34 | Average | +357% | +1% | -547 bps | 21 | new filing |
| ITGR | Integer Holdings Corporation | 60 | -1 | Average | -34% | -3%↓ | -282 bps | 90 | 2026-08-04 |
| KURA | Kura Oncology, Inc. | 60 | ±0 | Average | loss widened 3%↑ | +37%↑ | — | 79 | 2026-08-12 |
| PGEN | Precigen, Inc. Common Stock | 60 | ±0 | Average | to profit↑ | >+999%↑ | — | 96 | 2026-08-04 |
| REX | REX American Resources Corp. | 60 | +22 | Average | +147% | +6% | — | 59 | new filing |
| SPRY | ARS Pharmaceuticals, Inc. Common Stock | 60 | -1 | Average | loss widened 37%↑ | +114% | <-10,000 bps | 13 | 2026-08-13 |
| TKNO | Alpha Teknova, Inc. Common Stock | 60 | ±0 | Average33 | loss narrowed 14%↑ | +18%↑ | +1882 bps | 98 | 2026-08-06 |
| VSTM | Verastem, Inc. | 60 | ±0 | Average | loss narrowed 44%↓ | >+999% | — | 77 | 2026-08-06 |
| YCBD | cbdMD, Inc. Common Stock | 60 | -1 | Average | loss narrowed 48%↓ | +21%↑ | -993 bps | 17 | 2026-08-13 |
| ACOG | Alpha Cognition Inc. Common Stock | 59 | ±0 | Average | loss narrowed 38% | +268%↑ | — | 91 | 2026-08-13 |
| DCTH | Delcath Systems Inc | 59 | ±0 | Average | 0% | +21%↓ | -904 bps | 93 | 2026-08-06 |
| LFCR | Lifecore Biomedical, Inc. Common Stock | 59 | ±0 | Average | loss widened 111%↓ | +294%↑ | +3053 bps | 13 | 2026-08-05 |
| LYB | LyondellBasell Industries N.V. Class A | 59 | -1 | Average | +403% | +20%↑ | +155 bps | 43 | 2026-07-31 |
| SCNI | Scinai Immunotherapeutics Ltd. American Depositary Shares | 59 | ±0 | Average | to loss | >+999% | — | 4 | 2026-04-01 |
| SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | 59 | -1 | Average | loss narrowed 28% | +106% | — | 5 | 2026-08-14 |
| SYK | Stryker Corporation | 59 | -1 | Average | +44% | +9% | +719 bps | 24 | 2026-07-31 |
| TELA | TELA Bio, Inc. Common Stock | 59 | ±0 | Average | loss narrowed 9% | -4%↓ | +692 bps | 70 | 2026-08-11 |
| ARWR | Arrowhead Research CorporationObesity & Weight-Loss TherapeuticsHuman Therapeutics | 58 | -1 | Average | loss widened 8% | +171% | -1498 bps | 88 | 2026-08-04 |
| CBUS | Cibus, Inc. Class A Common Stock | 58 | ±0 | Average | loss narrowed 52% | +7% | — | 7 | 2026-08-13 |
| DHR | Danaher Corporation | 58 | -1 | Average | +60% | +6% | +203 bps | 54 | 2026-07-21 |
| DRS | Leonardo DRS, Inc. Common StockDefense Platforms & Technology | 58 | -1 | Average | +60%↑ | +10% | +106 bps | 24 | 2026-07-30 |
| KMDA | Kamada Ltd | 58 | -1 | Average | 0%↓ | +13% | — | 40 | 2026-03-11 |
| LODE | Comstock Inc. | 58 | ±0 | Average | loss widened 26%↓ | -20%↑ | — | 31 | 2026-07-23 |
| SXT | Sensient Technology Corporation | 58 | -1 | Average33 | +36%↑ | +12%↑ | +112 bps | 89 | 2026-08-04 |
| WDFC | Wd-40 Co | 58 | -1 | Average | +45% | +24%↑ | +118 bps | 33 | 2026-07-09 |
| ACAD | Acadia Pharmaceuticals Inc.Human Therapeutics | 57 | -1 | Average | +13% | +16%↑ | -1566 bps | 80 | 2026-08-05 |
| AME | Ametek, Inc. | 57 | ±0 | Average | +14% | +15% | -33 bps | 56 | 2026-08-04 |
| BCPC | Balchem Corporation | 57 | -1 | Average | +19% | +11% | +35 bps | 45 | 2026-07-31 |
| GELS | Gelteq Limited Ordinary Shares | 57 | ±0 | Average | loss widened 64% | +107% | — | 59 | 2025-11-17 |
| IMMP | Immutep Limited American Depositary Shares | 57 | -1 | Average | loss widened 19% | +32% | — | 2 | 2025-10-24 |
| IRMD | iRadimed Corporation | 57 | ±0 | Average | -9%↓ | 0%↓ | +125 bps | 27 | 2026-07-31 |
| MDXH | MDxHealth SA Ordinary Shares | 57 | ±0 | Average | loss narrowed 42% | +20% | +1410 bps | 4 | 2026-04-03 |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | 57 | ±0 | Average | loss widened 5% | — | — | 14 | 2026-08-12 |
| ROK | Rockwell Automation, Inc.Robotics & Autonomous Systems | 57 | -1 | Average | +40% | +8%↓ | +1235 bps | 66 | 2026-08-04 |
| UPB | Upstream Bio, Inc. Common Stock | 57 | -1 | Average | loss narrowed 1%↑ | -18% | — | 14 | 2026-08-11 |
| XBIO | Xenetic Biosciences, Inc. | 57 | ±0 | Average | loss narrowed 9%↓ | +12% | — | 92 | 2026-08-06 |
| COCP | Cocrystal Pharma, Inc. Common Stock | 56 | ±0 | Average | loss widened 15%↓ | — | — | 73 | 2026-08-13 |
| HCA | HCA Healthcare, Inc. | 56 | ±0 | Average | +11% | +4%↓ | +80 bps | 24 | 2026-07-28 |
| ICUI | ICU Medical Inc | 56 | -1 | Average | -47% | +1%↑ | +41 bps | 72 | 2026-08-06 |
| LUNR | Intuitive Machines, Inc. Class A Common StockSpace Economy | 56 | ±0 | Average | loss widened 32% | +304%↑ | — | 25 | 2026-08-13 |
| RLYB | Rallybio Corporation Common Stock | 56 | ±0 | Average | to profit | -100%↓ | — | 93 | 2026-08-06 |
| RMD | ResMed Inc. | 56 | ±0 | Average | +2%↓ | +9%↓ | +62 bps | 38 | 2026-08-13 |
| RPID | Rapid Micro Biosystems, Inc. Class A Common Stock | 56 | ±0 | Average | loss widened 0% | +11%↓ | +1067 bps | 5 | 2026-08-07 |
| ASPI | ASP Isotopes Inc. Common StockUranium & Nuclear Fuel | 55 | ±0 | Average | loss narrowed 74%↑ | +328% | — | 15 | 2026-08-14 |
| BKD | Brookdale Senior Living, Inc. | 55 | ±0 | Average | to profit↑ | -12%↓ | +183 bps | 30 | 2026-08-10 |
| CYPH | Cypherpunk Technologies Inc. Common Stock | 55 | ±0 | Average | to profit | 0% | — | 99 | 2026-08-12 |
| IKT | Inhibikase Therapeutics, Inc. Common Stock | 55 | -1 | Average | loss widened 0% | — | — | 69 | 2026-08-11 |
| LAB | Standard BioTools Inc. Common Stock | 55 | ±0 | Average | loss narrowed 22% | -8%↑ | -5986 bps | 19 | 2026-08-05 |
| PROF | Profound Medical Corp. Common Stock | 55 | ±0 | Average | to loss↓ | +25% | >+10,000 bps | 59 | 2026-08-06 |
| UFPT | UFP Technologies Inc | 55 | ±0 | Average | +21% | +15%↑ | -80 bps | 84 | 2026-08-06 |
| XLO | Xilio Therapeutics, Inc. Common Stock | 55 | +1 | Average | loss widened 106%↑ | +131%↓ | — | 72 | 2026-08-12 |
| A | Agilent Technologies Inc. | 54 | +3 | Average | +8% | +8% | +96 bps | 78 | 2026-09-01 |
| CHRS | Coherus Oncology, Inc. Common Stock | 54 | ±0 | Average | to loss | +40% | <-10,000 bps | 22 | 2026-08-05 |
| IBRX | ImmunityBio, Inc. Common Stock | 54 | ±0 | Average | loss widened 120% | +94%↓ | >+10,000 bps | 40 | 2026-08-04 |
| VTAK | Catheter Precision, Inc. | 54 | ±0 | Average | loss widened 142% | +381%↑ | — | 2 | 2026-08-14 |
| CBLL | CeriBell, Inc. Common Stock | 53 | ±0 | Average | loss widened 34%↑ | +33% | -148 bps | 80 | 2026-08-10 |
| ELF | e.l.f. Beauty, Inc. | 53 | -1 | Average | to profit | +7%↓ | — | 74 | 2026-08-06 |
| KRMD | KORU Medical Systems, Inc. Common Stock (DE) | 53 | ±0 | Average | to profit↑ | +18%↓ | +950 bps | 18 | 2026-08-05 |
| KVUE | Kenvue Inc. | 53 | ±0 | Average | +9% | +3% | +130 bps | 50 | 2026-08-06 |
| MGRX | Mangoceuticals, Inc. Common Stock | 53 | ±0 | Average | loss narrowed 84% | -59%↓ | — | 49 | 2026-08-13 |
| OPCH | Option Care Health, Inc. Common Stock | 53 | -1 | Average | +4% | +1% | -67 bps | 25 | 2026-07-29 |
| UPC | Universe Pharmaceuticals Inc. Class A Ordinary Shares | 53 | ±0 | Average | loss narrowed 99% | >+999% | +1850 bps | — | 2026-01-29 |
| APT | Alpha Pro Tech, Ltd. | 52 | -1 | Average33 | +50%↑ | +12%↑ | +203 bps | 46 | 2026-08-07 |
| NOC | Northrop Grumman Corp.Defense Platforms & TechnologySpace Economy | 52 | -1 | Average | -6% | +5% | +33 bps | 19 | 2026-07-21 |
| TT | Trane Technologies plcAI Data-Center Power & Cooling | 52 | ±0 | Average | +7% | +11%↑ | -45 bps | 52 | 2026-07-30 |
| XFOR | X4 Pharmaceuticals, Inc. Common Stock | 52 | ±0 | Average | loss narrowed 96% | +346% | <-10,000 bps | 24 | 2026-08-06 |
| ATAI | AtaiBeckley Inc. Common Stock | 51 | ±0 | Average | loss widened 213% | >+999% | — | 95 | 2026-08-11 |
| CGC | Canopy Growth Corporation Common Shares | 51 | ±0 | Average | — | — | >+10,000 bps | 32 | 2026-08-07 |
| ENSC | Ensysce Biosciences, Inc. Common Stock | 51 | -1 | Average | loss narrowed 75% | -15% | — | 66 | 2026-08-13 |
| EVGN | EVOGENE LTD. | 51 | ±0 | Average | to profit | -55% | — | 15 | 2026-03-26 |
| EW | Edwards Lifesciences Corp | 51 | ±0 | Average | -25% | +14% | -287 bps | 52 | 2026-08-04 |
| GCTK | GlucoTrack, Inc. Common Stock | 51 | ±0 | Average | -92% | -100%↓ | — | 3 | 2026-08-14 |
| IMCC | IM Cannabis Corp. Common Shares | 51 | -1 | Average | loss narrowed 41% | +1% | -223 bps | 2 | 2026-03-30 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 51 | ±0 | Average | to loss | -98% | >+10,000 bps | 71 | 2026-08-06 |
| NVO | Novo-Nordisk A/SObesity & Weight-Loss TherapeuticsHuman Therapeutics | 51 | -1 | Average | +2% | +6% | -289 bps | 67 | 2026-02-04 |
| RCEL | Avita Medical, Inc. Common Stock | 51 | ±0 | Average33 | loss narrowed 34%↑ | +18%↑ | +1600 bps | 96 | 2026-08-06 |
| REGN | Regeneron Pharmaceuticals IncObesity & Weight-Loss TherapeuticsHuman Therapeutics | 51 | ±0 | Average | -5% | +17% | -228 bps | 53 | 2026-07-30 |
| TDY | Teledyne Technologies Incorporated | 51 | -1 | Average | +21%↓ | +10%↑ | +176 bps | 37 | 2026-07-24 |
| TVTX | Travere Therapeutics, Inc. Common StockHuman Therapeutics | 51 | -1 | Average | loss widened 164%↓ | +48%↓ | +4474 bps | 98 | 2026-08-04 |
| ALC | Alcon Inc. Ordinary Shares | 50 | ±0 | Average | -22% | +4% | +1433 bps | 28 | 2026-05-05 |
| CLPT | ClearPoint Neuro, Inc. Common Stock | 50 | ±0 | Average | loss widened 81%↓ | +18% | -609 bps | 70 | 2026-08-03 |
| ECL | Ecolab, Inc. | 50 | -1 | Average | +3%↓ | +10% | -146 bps | 46 | 2026-08-06 |
| KEQU | Kewaunee Scientific Corp | 50 | -1 | Average | -31% | -7%↓ | -146 bps | 27 | 2026-06-26 |
| MD | Pediatrix Medical Group, Inc. | 50 | -1 | Average | +7% | +4%↑ | +254 bps | 85 | 2026-08-04 |
| MIR | Mirion Technologies, Inc.Advanced Nuclear Technology | 50 | -1 | Average | 0% | +20% | +13 bps | 21 | 2026-07-29 |
| NNOX | NANO-X IMAGING LTD Ordinary Shares | 50 | -1 | Average | loss widened 27% | +15% | -9790 bps | 5 | 2026-04-30 |
| PBH | Prestige Consumer Healthcare Inc. | 50 | ±0 | Average | -36% | +6% | -378 bps | 21 | 2026-08-06 |
| PCT | PureCycle Technologies, Inc. Common stock | 50 | ±0 | Average | loss narrowed 1% | +173%↑ | — | 55 | 2026-08-06 |
| QTI | QT Imaging Holdings, Inc. Common Stock | 50 | ±0 | Average | loss widened 436%↓ | +103%↓ | — | 8 | 2026-08-12 |
| CSTL | Castle Biosciences, Inc. Common Stock | 49 | -1 | Average | to loss | +20% | -233 bps | 78 | 2026-07-30 |
| DGX | Quest Diagnostics Inc. | 49 | ±0 | Average | +15% | +10%↑ | +8 bps | 69 | 2026-07-23 |
| LIN | Linde plc Ordinary Share | 49 | ±0 | Average | +11% | +9%↑ | -30 bps | 43 | 2026-07-31 |
| MTEX | Mannatech Inc. | 49 | ±0 | Average | to profit | +4%↑ | +295 bps | 77 | 2026-08-12 |
| NAGE | Niagen Bioscience, Inc. Common Stock | 49 | ±0 | Average | -75% | -4%↓ | -612 bps | 14 | 2026-08-04 |
| UG | United-Guardian, Inc. | 49 | -1 | Average | +14% | +10%↓ | -508 bps | 63 | 2026-08-11 |
| WAT | Waters Corp | 49 | ±0 | Average | to loss↓ | +113%↑ | -2059 bps | 85 | 2026-08-11 |
| WNW | Meiwu Technology Company Limited Ordinary Shares | 49 | ±0 | Average | to loss | >+999% | — | — | 2026-04-17 |
| FUL | H.B. Fuller Company | 48 | -1 | Average | +62% | +6%↑ | — | 36 | 2026-06-25 |
| MNKD | Mannkind Corporation | 48 | -1 | Average | to loss↑ | +43% | -1982 bps | 85 | 2026-08-05 |
| NGVT | Ingevity Corporation | 48 | ±0 | Average | to profit | -14% | +4916 bps | 56 | 2026-07-30 |
| OPK | Opko Health Inc. | 48 | -1 | Average33 | loss narrowed 95%↑ | +4%↑ | +1379 bps | 81 | 2026-07-27 |
| PACB | Pacific Biosciences of California, Inc.Genomics & Precision-Medicine Tools | 48 | -1 | Average | loss widened 0% | -2%↓ | >+10,000 bps | 41 | 2026-08-06 |
| PPBT | Purple Biotech Ltd. American Depositary Shares | 48 | ±0 | Average | -99% | 0% | — | 8 | 2026-03-19 |
| STVN | Stevanato Group S.p.A. | 48 | ±0 | Average | +19% | +7% | +216 bps | 86 | 2026-03-04 |
| TFX | Teleflex Incorporated | 48 | -1 | Average | -18%↑ | +29% | -655 bps | 72 | 2026-08-06 |
| TLX | Telix Pharmaceuticals Limited American Depositary Shares | 48 | ±0 | Average | to loss | +56% | — | 92 | 2026-02-20 |
| TRNS | Transcat Inc | 48 | ±0 | Average | -60% | +22% | -294 bps | 64 | 2026-08-04 |
| ACB | Aurora Cannabis Inc. Common Shares | 47 | -1 | Average | -89% | +27% | +1863 bps | 55 | 2026-06-11 |
| ICU | SeaStar Medical Holding Corporation Common Stock | 47 | ±0 | Average | loss widened 406%↓ | +82% | — | 66 | 2026-08-12 |
| MASS | 908 Devices Inc. Common Stock | 47 | ±0 | Average | loss narrowed 14% | +23%↑ | +6292 bps | 90 | 2026-08-11 |
| RAL | Ralliant Corporation | 47 | -1 | Average | +21%↑ | +13%↑ | -7033 bps | 88 | 2026-07-30 |
| SLN | Silence Therapeutics Plc American Depository Share | 47 | -1 | Average | loss narrowed 53%↑ | -100% | — | 96 | 2026-08-10 |
| SNDA | Sonida Senior Living, Inc. | 47 | ±0 | Average | loss widened 225%↓ | +122%↑ | -4944 bps | 72 | 2026-08-10 |
| BNKK | Bonk, Inc. Common Stock | 46 | ±0 | Average | to loss | >+999%↓ | — | 10 | 2026-08-14 |
| CCCC | C4 Therapeutics, Inc. | 46 | ±0 | Average33 | loss narrowed 51%↑ | +3%↑ | +6830 bps | 67 | 2026-08-11 |
| EQ | Equillium, Inc. Common Stock | 46 | ±0 | Average | loss narrowed 75% | -52%↓ | — | 76 | 2026-08-13 |
| NMTC | NeuroOne Medical Technologies Corporation Common Stock | 46 | +1 | Average | loss widened 833%↓ | +16% | — | 6 | 2026-08-13 |
| NNNN | Anbio Biotechnology Class A Ordinary Shares | 46 | -1 | Average | +163% | +6% | — | 5 | 2026-04-07 |
| NXGL | NexGel, Inc Common Stock | 46 | ±0 | Average | loss widened 344%↓ | +28%↑ | -1870 bps | 6 | 2026-08-17 |
| PEN | Penumbra, Inc. | 46 | -1 | Average | -23%↓ | +15%↓ | 0 bps | 42 | 2026-07-30 |
| PLUR | Pluri Inc. Common Stock | 46 | ±0 | Average | loss narrowed 41% | -61% | — | 7 | 2026-05-14 |
| CNMD | CONMED Corporation | 45 | -1 | Average | +12%↑ | 0% | -496 bps | 75 | 2026-07-29 |
| KRO | Kronos Worldwide, Inc. | 45 | ±0 | Average | to profit↑ | +13%↑ | -764 bps | 92 | 2026-08-05 |
| MITQ | Moving iMage Technologies, Inc. | 45 | ±0 | Average | loss narrowed 50% | -5% | +528 bps | 55 | 2026-05-14 |
| NVCR | NovoCure Limited Ordinary Shares | 45 | ±0 | Average | loss narrowed 64% | +16%↑ | +534 bps | 76 | 2026-07-23 |
| OFIX | Orthofix Medical Inc. Common Stock (DE) | 45 | -1 | Average | loss widened 8%↓ | +4% | +708 bps | 19 | 2026-08-05 |
| PAVM | PAVmed Inc. Common Stock | 45 | ±0 | Average | loss widened 18% | +450% | — | 7 | 2026-08-13 |
| POCI | Precision Optics Corporation, Inc. Common Stock | 45 | ±0 | Average | loss narrowed 97% | +108%↑ | +1505 bps | 48 | 2026-05-13 |
| PRPO | Precipio, Inc. Common Stock | 45 | ±0 | Average | to loss↓ | +25%↓ | +1158 bps | 44 | 2026-08-14 |
| SCYX | SCYNEXIS, Inc. | 45 | ±0 | Average | to profit | -83% | — | 16 | 2026-08-10 |
| SRZN | Surrozen, Inc. Common | 45 | ±0 | Average | to loss | +409% | <-10,000 bps | 20 | 2026-08-06 |
| TOMZ | TOMI Environmental Solutions, Inc. | 45 | -1 | Average | loss narrowed 17% | +118%↑ | — | 27 | 2026-08-14 |
| UTHR | United Therapeutics CorpHuman Therapeutics | 45 | ±0 | Average | +13% | -2%↓ | -261 bps | 39 | 2026-08-05 |
| EUDA | EUDA Health Holdings Limited Ordinary Shares | 44 | — | Average | loss widened 215% | +70% | — | 27 | 2026-04-28 |
| IPSC | Century Therapeutics, Inc. Common Stock | 44 | -1 | Average | loss narrowed 55% | -100% | — | 19 | 2026-08-12 |
| JANX | Janux Therapeutics, Inc. Common Stock | 44 | -1 | Average | loss narrowed 36%↑ | — | — | 79 | 2026-08-06 |
| RDNT | RadNet, Inc. Common Stock | 44 | ±0 | Average | -47% | +25%↑ | -30 bps | 76 | 2026-08-10 |
| RGNX | REGENXBIO Inc. | 44 | +1 | Average | to profit | +406% | +1158 bps | 38 | 2026-08-06 |
| UL | Unilever plc | 44 | ±0 | Average | +89% | -17% | +242 bps | 42 | 2026-03-12 |
| ADCT | ADC Therapeutics SAHuman Therapeutics | 43 | -1 | Average | loss narrowed 78% | +3%↓ | +7904 bps | 4 | 2026-08-13 |
| ERNA | Ernexa Therapeutics Inc. Common Stock | 43 | ±0 | Average | loss widened 457% | — | — | 12 | 2026-08-06 |
| FCUV | Focus Universal Inc. Common Stock | 43 | ±0 | Average | loss widened 999%↓ | >+999%↑ | — | 6 | 2026-08-14 |
| GURE | Gulf Resources, Inc. (NV) Common Stock | 43 | +3 | Average | loss narrowed 36% | +48%↓ | — | 16 | 2026-08-28 |
| HIMS | Hims & Hers Health, Inc.Obesity & Weight-Loss Therapeutics | 43 | ±0 | Average | to loss↓ | +38% | -1223 bps | 58 | 2026-08-10 |
| LGVN | Longeveron Inc. Common Stock | 43 | -1 | Average | loss narrowed 42% | -9% | — | 27 | 2026-08-12 |
| LUNG | Pulmonx Corporation Common Stock | 43 | -1 | Average | loss narrowed 37% | -5% | +989 bps | 54 | 2026-08-04 |
| MCRB | Seres Therapeutics, Inc. | 43 | ±0 | Average | to profit↑ | — | — | 12 | 2026-08-05 |
| PRM | Perimeter Solutions, Inc. | 43 | ±0 | Average | loss widened 405% | +31% | -6334 bps | 83 | 2026-07-31 |
| BDRX | Biodexa Pharmaceuticals plc American Depositary Shs | 42 | ±0 | Average | loss narrowed 90% | -45% | — | 3 | 2026-03-27 |
| GUTS | Fractyl Health, Inc. Common Stock | 42 | -1 | Average | loss narrowed 72% | -57% | — | 86 | 2026-08-10 |
| ILMN | Illumina IncGenomics & Precision-Medicine Tools | 42 | -1 | Average | -9%↓ | +9% | -1053 bps | 93 | 2026-07-31 |
| ROIV | Roivant Sciences Ltd. Common Shares | 42 | -1 | Average | loss narrowed 21% | -34% | — | 87 | 2026-08-06 |
| ANIX | Anixa Biosciences, Inc. | 41 | -17 | Average | loss widened 14% | — | — | 40 | new filing |
| BGM | BGM Group Ltd. Class A Ordinary Shares | 41 | ±0 | Average | loss narrowed 10% | +51% | -3093 bps | 5 | 2026-07-21 |
| BMRN | BioMarin Pharmaceuticals IncHuman Therapeutics | 41 | -1 | Average | -81% | +20% | -2095 bps | 62 | 2026-08-06 |
| CAMT | Camtek LtdSemiconductors & Equipment | 41 | ±0 | Average | -57% | +16% | +67 bps | 35 | 2026-03-19 |
| CUE | Cue Biopharma, Inc. | 41 | ±0 | Average | loss widened 999%↓ | +167%↓ | — | 98 | 2026-08-14 |
| ESI | Element Solutions Inc. | 41 | ±0 | Average | -43% | +41%↑ | -43 bps | 57 | 2026-07-28 |
| MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | 41 | -1 | Average | loss narrowed 70% | +9% | +8892 bps | 96 | 2026-08-07 |
| TWST | Twist Bioscience Corporation Common StockGenomics & Precision-Medicine Tools | 41 | ±0 | Average | to loss↓ | +23%↑ | +572 bps | 98 | 2026-08-03 |
| VLTO | Veralto Corporation | 41 | -1 | Average | +13%↑ | +7% | -31 bps | 53 | 2026-07-29 |
| BBLG | Bone Biologics Corp Common Stock | 40 | -1 | Average | loss narrowed 68% | — | — | 8 | 2026-08-14 |
| CORT | Corcept Therapeutics Inc.Human Therapeutics | 40 | ±0 | Average | +24% | +32% | -1347 bps | 99 | 2026-07-29 |
| EVMN | Evommune, Inc. | 40 | ±0 | Average | loss narrowed 90%↓ | — | — | 9 | 2026-08-06 |
| GEVO | Gevo, Inc. | 40 | ±0 | Average | to loss↓ | +7%↓ | -3047 bps | 18 | 2026-08-06 |
| LH | Labcorp Holdings Inc. | 40 | -1 | Average | +28% | +6%↑ | +160 bps | 67 | 2026-08-05 |
| RPM | RPM International, Inc. | 40 | -1 | Average | -1% | +7% | +32 bps | 46 | 2026-07-22 |
| SENS | Senseonics Holdings, Inc. Common Stock | 40 | ±0 | Average33 | loss widened 999%↑ | +118%↑ | +3174 bps | 91 | 2026-08-06 |
| STOK | Stoke Therapeutics, Inc. Common Stock | 40 | ±0 | Average | loss widened 132%↑ | -33% | <-10,000 bps | 23 | 2026-08-03 |
| TNON | Tenon Medical, Inc. Common Stock | 40 | ±0 | Average | loss widened 999% | +127% | — | 3 | 2026-08-13 |
| VNRX | VolitionRx Limited | 40 | ±0 | Average | loss widened 999% | -2% | — | 2 | 2026-08-13 |
| AMS | American Shared Hospital Services | 39 | -1 | Average | loss widened 75%↓ | +19%↑ | +383 bps | 18 | 2026-08-13 |
| CLNN | Clene Inc. Common Stock | 39 | ±0 | Average | loss widened 38% | +233% | — | 16 | 2026-08-14 |
| COCH | Envoy Medical, Inc. Class A Common Stock | 39 | -1 | Average | loss narrowed 78%↑ | -35%↓ | — | 40 | 2026-08-10 |
| CPHI | China Pharma Holdings, Inc. | 39 | -1 | Average | loss narrowed 75% | -8% | — | — | 2026-08-14 |
| DBVT | DBV Technologies S.A. | 39 | -1 | Average | loss narrowed 61%↑ | -52%↓ | — | 15 | 2026-07-16 |
| INBS | Intelligent Bio Solutions Inc. Common Stock | 39 | -6 | Average | loss widened 864% | +36%↓ | — | 11 | 2026-08-19 |
| IPAR | Interparfums, Inc. Common Stock | 39 | ±0 | Average | -4%↓ | +2% | -168 bps | 72 | 2026-08-04 |
| TMO | Thermo Fisher Scientific, Inc. | 39 | -1 | Average | +9% | +10% | +45 bps | 76 | 2026-07-31 |
| BLRX | BioLineRX Ltd | 38 | ±0 | Average | to profit | -96% | — | 45 | 2026-03-23 |
| CHD | Church & Dwight Co., Inc. | 38 | ±0 | Average | +9%↑ | +2% | +556 bps | 41 | 2026-07-31 |
| DNLI | Denali Therapeutics Inc. Common StockHuman Therapeutics | 38 | ±0 | Average | loss narrowed 6% | — | — | 47 | 2026-08-06 |
| LEXX | Lexaria Bioscience Corp. Common Stock | 38 | -1 | Average | loss narrowed 62%↑ | -100% | — | 7 | 2026-07-13 |
| MTD | Mettler-Toledo International | 38 | -1 | Average | +18% | +4%↓ | +6 bps | 56 | 2026-07-31 |
| OCGN | Ocugen, Inc. Common Stock | 38 | -1 | Average | loss widened 40% | +8% | — | 8 | 2026-08-06 |
| OPXS | Optex Systems Holdings, INC | 38 | -1 | Average | -18%↑ | -12%↓ | -286 bps | 22 | 2026-08-11 |
| RDY | Dr. Reddy's Laboratories Limited American Depositary Shares | 38 | -1 | Average | -80% | +17% | -219 bps | 26 | 2026-05-29 |
| SUPN | Supernus Pharmaceuticals, Inc. | 38 | -1 | Average | to loss | +32% | -2535 bps | 24 | 2026-08-03 |
| ZLAB | Zai Lab Limited American Depositary SharesHuman Therapeutics | 38 | ±0 | Average | loss widened 25% | -3% | -142 bps | 80 | 2026-08-06 |
| ALGN | Align Technology Inc | 37 | -1 | Average | -12%↓ | +4% | -192 bps | 32 | 2026-08-05 |
| CITR | CitroTech Inc. | 37 | ±0 | Average | loss narrowed 5%↑ | -59% | — | 12 | 2026-08-10 |
| DSGN | Design Therapeutics, Inc. Common Stock | 37 | -1 | Average | loss narrowed 6% | — | — | 90 | 2026-08-03 |
| ENTA | Enanta Pharmaceuticals, Inc | 37 | -1 | Average | loss narrowed 21%↓ | -22%↓ | >+10,000 bps | 36 | 2026-08-12 |
| IONS | Ionis Pharmaceuticals, Inc. Common StockHuman Therapeutics | 37 | -1 | Average | to loss | -41% | — | 22 | 2026-07-29 |
| IRIX | Iridex Corp | 37 | -1 | Average | loss widened 17% | -7%↓ | +334 bps | 10 | 2026-08-18 |
| MIRM | Mirum Pharmaceuticals, Inc. Common StockHuman Therapeutics | 37 | ±0 | Average | loss widened 783% | +38%↓ | <-10,000 bps | 63 | 2026-08-05 |
| TDOC | Teladoc Health, Inc. | 37 | ±0 | Average | loss widened 11%↓ | -4%↓ | +302 bps | 65 | 2026-07-30 |
| XERS | Xeris Biopharma Holdings, Inc. Common Stock | 37 | ±0 | Average | loss widened 999%↓ | +29%↓ | +1490 bps | 84 | 2026-08-06 |
| ALKS | Alkermes Inc. plcHuman Therapeutics | 36 | -1 | Average | -100% | +27% | -1783 bps | 93 | 2026-07-28 |
| BDSX | Biodesix, Inc. Common Stock | 36 | ±0 | Average | loss widened 787%↑ | +34% | +2452 bps | 86 | 2026-08-05 |
| CL | Colgate-Palmolive Company | 36 | -1 | Average | -5%↑ | +5% | -655 bps | 46 | 2026-07-31 |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | 36 | ±0 | Average | +18% | -2% | +223 bps | 39 | 2026-07-30 |
| HUMA | Humacyte, Inc. Common Stock | 36 | ±0 | Average | loss narrowed 33% | +35%↑ | — | 9 | 2026-08-12 |
| MMED | MiniMed Group, Inc. Common Stock | 36 | -1 | Average | loss widened 55% | +14% | — | 78 | new filing |
| NIKI | Niki BioSolutions, Inc. Common Stock | 36 | ±0 | Average | loss narrowed 76% | -67% | — | — | 2026-03-27 |
| APRE | Aprea Therapeutics, Inc. Common stock | 35 | ±0 | Average | loss narrowed 87%↑ | -98% | — | 50 | 2026-08-12 |
| IBIO | iBio, Inc. Common Stock | 35 | -1 | Average | loss narrowed 81% | -100% | — | 10 | 2026-08-28 |
| IVF | INVO Fertility, Inc. Common Stock | 35 | ±0 | Average | to profit | +17% | — | 4 | 2026-08-14 |
| NUWE | Nuwellis, Inc. Common Stock | 35 | -1 | Average | loss narrowed 56% | +14% | — | 1 | 2026-08-13 |
| OWLT | Owlet, Inc. | 35 | ±0 | Average | loss narrowed 98% | +30% | +1235 bps | 24 | 2026-08-14 |
| ACON | Aclarion, Inc. Common Stock | 34 | -1 | Average | loss narrowed 59%↓ | +30% | — | 21 | 2026-08-06 |
| BRTX | BioRestorative Therapies, Inc. Common Stock (NV) | 34 | -1 | Average | loss narrowed 81%↑ | -7%↑ | — | 10 | 2026-05-14 |
| CYRX | CryoPort, Inc. Common Stock | 34 | ±0 | Average | to loss↓ | +8% | +440 bps | 96 | 2026-08-06 |
| FOSL | Fossil Group, Inc. | 34 | -1 | Average | loss narrowed 97%↑ | -4% | +723 bps | 62 | 2026-08-13 |
| HROW | Harrow, Inc. Common Stock | 34 | ±0 | Average | to loss↓ | +11% | -732 bps | 47 | 2026-08-10 |
| IOSP | Innospec Inc. | 34 | -1 | Average | +33% | +12%↑ | -213 bps | 84 | 2026-08-05 |
| LOOP | Loop Industries, Inc. Common Stock | 34 | ±0 | Average | loss widened 0% | -29% | — | 6 | 2026-07-14 |
| NEU | NewMarket Corporation | 34 | -1 | Average | +23%↑ | +7% | -181 bps | 90 | 2026-07-30 |
| OM | Outset Medical, Inc. Common Stock | 34 | ±0 | Average | loss narrowed 7%↓ | +1% | +1013 bps | 50 | 2026-08-06 |
| RVTY | Revvity, Inc. | 34 | -1 | Average | +2%↓ | +1% | -125 bps | 85 | 2026-08-11 |
| SNGX | Soligenix, Inc. Common Stock | 34 | ±0 | Average | loss narrowed 85% | -100% | — | 5 | 2026-08-07 |
| AXGN | Axogen, Inc. Common Stock | 33 | -1 | Average | to loss↓ | +23% | -596 bps | 82 | 2026-07-29 |
| INGN | Inogen Inc | 33 | -1 | Average | loss narrowed 7% | +5% | +125 bps | 29 | 2026-08-07 |
| LTBR | Lightbridge Corp.Uranium & Nuclear Fuel | 33 | -1 | Average | loss widened 12% | — | — | 13 | 2026-08-06 |
| PIII | P3 Health Partners Inc. Common Stock | 33 | -1 | Average | loss narrowed 90% | +9% | +1184 bps | 98 | 2026-08-10 |
| TPST | Tempest Therapeutics, Inc. Common Stock | 33 | ±0 | Average | loss narrowed 84%↑ | -2% | — | 6 | 2026-08-13 |
| ZTS | ZOETIS INC. | 33 | -1 | Average | +2% | 0%↓ | -97 bps | 14 | 2026-08-06 |
| ALXO | ALX Oncology Holdings Inc. Common Stock | 32 | ±0 | Average | loss narrowed 73%↑ | — | — | 34 | 2026-08-06 |
| AMPH | Amphastar Pharmaceuticals, Inc. | 32 | ±0 | Average | +5% | +5%↑ | -948 bps | 79 | 2026-08-06 |
| CRBU | Caribou Biosciences, Inc. Common Stock | 32 | -1 | Average | loss narrowed 59%↑ | -44%↓ | — | 18 | 2026-08-13 |
| GOVX | GeoVax Labs, Inc. New | 32 | ±0 | Average | loss widened 177% | -100% | — | 4 | 2026-07-27 |
| JNJ | Johnson & Johnson | 32 | ±0 | Average | -1% | +7% | -913 bps | 63 | 2026-07-23 |
| KZIA | Kazia Therapeutics Limited American Depositary Shares | 32 | ±0 | Average | loss narrowed 63% | -98% | — | 85 | 2025-11-07 |
| SABS | SAB Biotherapeutics, Inc. Common Stock | 32 | ±0 | Average | loss narrowed 74% | -62% | — | 22 | 2026-08-06 |
| ST | Sensata Technologies Holding plc | 32 | -1 | Average | +71% | +5%↑ | +393 bps | 73 | 2026-07-29 |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Human Therapeutics | 32 | ±0 | Average | -26% | +7% | +246 bps | 49 | 2026-06-17 |
| WOK | WORK Medical Technology Group LTD Class A Ordinary Shares | 32 | ±0 | Average | loss narrowed 85% | -14% | — | — | 2026-01-30 |
| CODX | Co-Diagnostics, Inc. Common Stock | 31 | ±0 | Average | loss widened 535%↑ | +2% | — | 6 | 2026-08-13 |
| CSBR | Champions Oncology, Inc. | 31 | ±0 | Average | loss narrowed 58% | +12% | -991 bps | 32 | 2026-07-27 |
| GEHC | GE HealthCare Technologies Inc. Common Stock | 31 | -1 | Average | -31%↓ | +7%↑ | -108 bps | 34 | 2026-07-29 |
| PG | Procter & Gamble Company | 31 | ±0 | Average | -15% | +2% | -157 bps | 40 | 2026-08-04 |
| PYXS | Pyxis Oncology, Inc. Common Stock | 31 | -1 | Average | loss widened 33%↓ | — | — | 97 | 2026-08-13 |
| RGEN | Repligen Corp | 31 | -1 | Average | -65%↓ | +12%↓ | +1177 bps | 87 | 2026-07-29 |
| SMG | The Scotts Miracle-Gro Company | 31 | -1 | Average | -25% | -1% | +334 bps | 35 | 2026-08-05 |
| XRAY | DENTSPLY SIRONA Inc. | 31 | -1 | Average | to profit | -4%↓ | +1971 bps | 28 | 2026-08-06 |
| AMRN | Amarin Corp Plc | 30 | -1 | Average | loss narrowed 33% | -42% | +2845 bps | 32 | 2026-07-29 |
| ARMP | Armata Pharmaceuticals, Inc. Common Stock | 30 | -1 | Average | loss narrowed 40%↑ | +16% | — | 9 | 2026-08-12 |
| BIO | Bio-Rad Laboratories, Inc.Class A | 30 | ±0 | Average | +19% | 0%↓ | — | 86 | 2026-08-04 |
| ELUT | Elutia Inc. Class A Common Stock | 30 | ±0 | Average | loss narrowed 35%↑ | -61%↓ | — | 21 | 2026-08-14 |
| ENTX | Entera Bio Ltd. Ordinary Shares | 30 | ±0 | Average | +133%↑ | — | — | 96 | 2026-08-07 |
| IMDX | Insight Molecular Diagnostics Inc. Common Stock | 30 | ±0 | Average | loss widened 3%↓ | -54% | — | 22 | 2026-08-10 |
| INSP | Inspire Medical Systems, Inc. | 30 | -1 | Average | to profit | -8%↓ | +122 bps | 67 | 2026-08-03 |
| KRRO | Korro Bio, Inc. Common Stock | 30 | ±0 | Average | loss narrowed 61%↑ | -100% | — | 64 | 2026-08-06 |
| LFWD | Lifeward Ltd. Ordinary Shares | 30 | ±0 | Laggard | loss widened 610% | +16% | — | 66 | 2026-08-14 |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common StockHuman Therapeutics | 30 | ±0 | Laggard | loss narrowed 39%↓ | -60%↓ | +1409 bps | 38 | 2026-08-05 |
| SRPT | Sarepta Therapeutics,, Inc. Common StockHuman Therapeutics | 30 | ±0 | Laggard | to loss | -36% | — | 71 | 2026-08-05 |
| USPH | US Physical Therapy Inc | 30 | ±0 | Average | -57%↑ | +8% | -70 bps | 45 | 2026-08-07 |
| WALD | Waldencast plc Class A Ordinary Share | 30 | ±0 | Laggard | loss widened 415% | -1% | -5857 bps | 33 | 2026-03-13 |
| ACNT | Ascent Industries Co. Common Stock | 29 | -1 | Laggard | -89% | +38%↑ | -515 bps | 70 | 2026-08-04 |
| BYSI | BeyondSpring Inc. Ordinary Shares | 29 | ±0 | Laggard | loss narrowed 80% | — | — | 10 | 2026-08-14 |
| GNLX | Genelux Corporation Common Stock | 29 | ±0 | Laggard | loss widened 5% | — | — | 35 | 2026-08-13 |
| IART | Integra LifeSciences Holdings | 29 | ±0 | Laggard | to profit↑ | +1% | +3485 bps | 93 | 2026-07-29 |
| KIDS | OrthoPediatrics Corp. Common Stock | 29 | -1 | Laggard | loss widened 0%↓ | +15% | +682 bps | 76 | 2026-08-05 |
| PLSE | Pulse Biosciences, Inc Common Stock (DE) | 29 | -1 | Laggard | loss widened 29%↓ | — | — | 98 | 2026-08-06 |
| PULM | Pulmatrix, Inc. Common Stock | 29 | ±0 | Laggard | loss narrowed 31%↓ | -100%↓ | — | 16 | 2026-08-13 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 29 | ±0 | Laggard | to loss | +11%↓ | -2184 bps | 47 | 2026-08-03 |
| ACET | Adicet Bio, Inc. Common Stock | 28 | ±0 | Laggard | loss widened 485%↑ | -100% | — | 81 | 2026-08-05 |
| AORT | Artivion, Inc. | 28 | -1 | Laggard | to loss | +11%↓ | +4 bps | 17 | 2026-08-07 |
| CLX | Clorox Company | 28 | -1 | Laggard33 | +3%↑ | 0%↑ | +118 bps | 25 | 2026-08-07 |
| ELOX | Eloxx Pharmaceuticals, Inc. Common Stock | 28 | ±0 | Laggard | loss narrowed 42% | -100% | — | 99 | 2026-08-11 |
| IFF | International Flavors & Fragrances Inc. | 28 | -1 | Laggard | -92%↓ | -29% | +1047 bps | 77 | 2026-08-04 |
| INO | Inovio Pharmaceuticals, Inc. | 28 | ±0 | Laggard | loss narrowed 89% | — | — | 22 | 2026-08-12 |
| KLAC | KLA Corporation Common StockSemiconductors & Equipment | 28 | ±0 | Laggard | to loss↓ | +15%↑ | +308 bps | 75 | 2026-08-06 |
| LENZ | LENZ Therapeutics, Inc. Common Stock | 28 | ±0 | Laggard | loss widened 92%↑ | +10% | — | 7 | 2026-08-11 |
| NTLA | Intellia Therapeutics, IncHuman Therapeutics | 28 | ±0 | Laggard | loss narrowed 18%↓ | -46%↓ | >+10,000 bps | 38 | 2026-08-06 |
| RXST | RxSight, Inc. Common Stock | 28 | ±0 | Laggard | loss widened 0% | -19% | -1660 bps | 26 | 2026-08-05 |
| SRRK | Scholar Rock Holding Corporation Common StockObesity & Weight-Loss Therapeutics | 28 | ±0 | Laggard | loss narrowed 14% | — | — | 82 | 2026-08-06 |
| STEX | Streamex Corp. Common Stock | 28 | ±0 | Laggard | loss narrowed 89%↑ | — | — | 6 | 2026-08-14 |
| TMCI | Treace Medical Concepts, Inc. Common Stock | 28 | ±0 | Laggard | loss narrowed 14%↑ | -4% | -376 bps | 99 | 2026-08-07 |
| VRCA | Verrica Pharmaceuticals Inc. Common Stock | 28 | ±0 | Laggard | to loss | -54%↓ | >+10,000 bps | 25 | 2026-08-06 |
| YDES | YD Bio Limited Ordinary Shares | 28 | ±0 | Laggard | loss widened 500% | +17% | — | 10 | 2026-04-30 |
| EBS | Emergent Biosolutions, Inc. | 27 | ±0 | Laggard | loss widened 999% | +66% | -2108 bps | 20 | 2026-08-06 |
| EL | The Estee Lauder Companies Inc. Class A | 27 | -3 | Laggard | loss narrowed 80% | +6% | +1066 bps | 58 | 2026-08-19 |
| GRCE | Grace Therapeutics, Inc. Common Stock | 27 | ±0 | Laggard | loss narrowed 41% | -100% | — | 12 | 2026-08-13 |
| LXFR | Luxfer Holdings PLC Ordinary Shares | 27 | +17 | Laggard | +80%↑ | -8% | -284 bps | 89 | 2026-07-28 |
| MREO | Mereo BioPharma Group plc American Depositary Shares | 27 | -1 | Laggard | loss narrowed 50% | -100% | — | 14 | 2026-08-11 |
| ALEC | Alector, Inc. Common Stock | 26 | -1 | Laggard | loss narrowed 30% | -58%↑ | <-10,000 bps | 39 | 2026-08-06 |
| ARDT | Ardent Health, Inc. | 26 | ±0 | Laggard | -77% | -1% | -354 bps | 75 | 2026-08-10 |
| ARQ | Arq, Inc. Common Stock | 26 | -1 | Laggard | loss narrowed 60%↑ | +5%↓ | -4434 bps | 79 | 2026-08-10 |
| BNTC | Benitec Biopharma Inc. Common Stock | 26 | -1 | Laggard | loss widened 0%↑ | — | — | 48 | 2026-05-14 |
| CLGN | CollPlant Biotechnologies Ltd Ordinary Shares | 26 | ±0 | Laggard | -24% | -28% | — | 12 | 2026-03-26 |
| CRDF | Cardiff Oncology, Inc. Common Stock | 26 | ±0 | Laggard | loss narrowed 33% | -14% | — | 13 | 2026-08-11 |
| FEMY | Femasys Inc. Common Stock | 26 | ±0 | Laggard | loss widened 731%↓ | -19%↓ | — | 4 | 2026-08-14 |
| IMRX | Immuneering Corporation Class A Common Stock | 26 | -1 | Laggard | loss narrowed 33%↓ | -100% | — | 26 | 2026-08-05 |
| LHX | L3Harris Technologies, Inc.Defense Platforms & TechnologySpace Economy | 26 | ±0 | Laggard | +28% | +8% | +139 bps | 17 | 2026-07-30 |
| OCUL | Ocular Therapeutix, Inc. | 26 | ±0 | Laggard | loss narrowed 10%↑ | 0% | <-10,000 bps | 65 | 2026-08-03 |
| TVRD | Tvardi Therapeutics, Inc. Common Stock | 26 | ±0 | Laggard | loss narrowed 31%↓ | +20% | — | 10 | 2026-08-14 |
| BCHT | Birchtech Corp. | 25 | ±0 | Laggard | loss widened 450% | +16% | +669 bps | 12 | 2026-08-13 |
| FATE | Fate Therapeutics, Inc. | 25 | ±0 | Laggard | loss narrowed 14%↓ | +9%↑ | — | 96 | 2026-08-13 |
| ICCM | IceCure Medical Ltd. Ordinary Shares | 25 | ±0 | Laggard | -20% | +3% | — | — | 2026-03-17 |
| LPCN | Lipocine Inc. | 25 | ±0 | Laggard | loss narrowed 22%↑ | -69% | — | 4 | 2026-08-04 |
| LSTA | Lisata Therapeutics, Inc. Common Stock | 25 | ±0 | Laggard | loss narrowed 41% | -100% | — | 6 | 2026-08-06 |
| MSAI | MultiSensor AI Holdings, Inc. Common Stock | 25 | ±0 | Laggard | loss widened 999%↓ | +19% | — | 7 | 2026-08-13 |
| ABT | Abbott Laboratories | 24 | -1 | Laggard | -20% | +8% | +23 bps | 41 | 2026-07-28 |
| AXTA | Axalta Coating Systems Ltd. | 24 | ±0 | Laggard | -7% | -1% | -71 bps | 74 | 2026-07-29 |
| BCYC | Bicycle Therapeutics plc American Depositary Shares | 24 | ±0 | Laggard | loss narrowed 37% | -78% | >+10,000 bps | 21 | 2026-07-30 |
| BNGO | Bionano Genomics, Inc. Common Stock | 24 | ±0 | Laggard | loss narrowed 68% | +21%↑ | >+10,000 bps | 56 | 2026-08-10 |
| GYRE | Gyre Therapeutics, Inc. Common Stock | 24 | ±0 | Laggard | to loss | +9% | -2304 bps | 26 | 2026-08-07 |
| HAE | Haemonetics Corporation | 24 | -1 | Laggard | +3% | +6%↑ | -567 bps | 93 | 2026-08-06 |
| PSNL | Personalis, Inc. Common StockGenomics & Precision-Medicine Tools | 24 | -1 | Laggard | loss widened 30% | +30% | -7444 bps | 96 | 2026-08-04 |
| QSI | Quantum-Si Incorporated Class A Common Stock | 24 | ±0 | Laggard | loss narrowed 31% | -42% | — | 19 | 2026-08-13 |
| SERA | Sera Prognostics, Inc. Class A Common Stock | 24 | ±0 | Laggard | loss widened 12%↓ | +76% | — | 59 | 2026-08-12 |
| TCRX | TScan Therapeutics, Inc. Common Stock | 24 | -1 | Laggard | loss narrowed 18% | -66%↓ | — | 5 | 2026-08-12 |
| AARD | Aardvark Therapeutics, Inc. Common Stock | 23 | ±0 | Laggard | loss widened 0% | — | — | 44 | 2026-08-11 |
| AKTX | Akari Therapeutics plc ADR (0.01 USD) | 23 | ±0 | Laggard | 0% | -39% | — | — | 2026-08-13 |
| ANGO | AngioDynamics, Inc. | 23 | -1 | Laggard | loss widened 87%↓ | +8%↓ | +119 bps | 86 | 2026-07-14 |
| AVTX | Avalo Therapeutics, Inc. Common Stock | 23 | -1 | Laggard | loss narrowed 57%↑ | -100%↓ | — | 50 | 2026-08-06 |
| BAX | Baxter International Inc. | 23 | -1 | Laggard | +33%↑ | +5% | -485 bps | 85 | 2026-07-30 |
| EMN | Eastman Chemical Company | 23 | ±0 | Laggard | +33%↑ | +10%↑ | -469 bps | 51 | 2026-07-31 |
| IBO | Impact BioMedical, Inc. | 23 | ±0 | Laggard | loss narrowed 99% | -57% | — | 26 | 2026-08-07 |
| IDYA | IDEAYA Biosciences, Inc. Common Stock | 23 | ±0 | Laggard | loss widened 39%↓ | — | — | 63 | 2026-08-04 |
| IGC | IGC Pharma, Inc. | 23 | -1 | Laggard | loss widened 50%↓ | -19%↓ | — | 45 | 2026-08-14 |
| MMM | 3M Company | 23 | ±0 | Laggard | +33% | +2%↑ | — | 57 | 2026-07-21 |
| OGN | Organon & Co. | 23 | -1 | Laggard | -29% | -2%↑ | -259 bps | 97 | 2026-07-31 |
| STXS | Stereotaxis, Inc. Common Stock | 23 | -1 | Laggard | loss widened 0%↓ | -13% | -60 bps | 17 | 2026-08-12 |
| TXMD | TherapeuticsMD, Inc. | 23 | ±0 | Laggard | -80% | -9% | — | 38 | 2026-08-11 |
| BHC | Bausch Health Companies Inc | 22 | ±0 | Laggard | +70% | +13%↑ | -805 bps | 65 | 2026-07-30 |
| GLAS | Glass House Brands Inc. | 22 | -1 | Laggard | loss widened 162% | -9% | -1194 bps | — | 2026-08-13 |
| NN | NextNav Inc. Common Stock | 22 | ±0 | Laggard | loss narrowed 50% | -4%↑ | — | 34 | 2026-08-11 |
| OPTX | Syntec Optics Holdings, Inc. Class A Common Stock | 22 | -1 | Laggard | to profit | +26% | -135 bps | 56 | 2026-08-10 |
| TLPH | Talphera, Inc. Common Stock | 22 | ±0 | Laggard | loss narrowed 40% | — | — | 87 | 2026-08-12 |
| TROX | TRONOX LIMITED CL A ORDINARY SHARESRare Earths & Strategic Materials | 22 | -1 | Laggard | loss widened 102% | +19% | -737 bps | 17 | 2026-08-06 |
| VNT | Vontier Corporation | 22 | ±0 | Laggard | -68% | -2%↓ | +80 bps | 28 | 2026-08-06 |
| VTRS | Viatris Inc. Common Stock | 22 | ±0 | Laggard | to loss | +5% | +1791 bps | 71 | 2026-08-06 |
| ACRS | Aclaris Therapeutics, Inc. | 21 | ±0 | Laggard | loss widened 15% | -8% | — | 91 | 2026-08-06 |
| AIRS | AirSculpt Technologies, Inc. Common Stock | 21 | ±0 | Laggard | loss widened 100%↓ | -3% | -311 bps | 59 | 2026-08-10 |
| AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | 21 | ±0 | Laggard | loss narrowed 15% | — | — | 97 | 2026-08-06 |
| BLCO | Bausch + Lomb Corporation | 21 | ±0 | Laggard | loss narrowed 78%↑ | +9%↓ | +533 bps | 50 | 2026-07-29 |
| KODK | EASTMAN KODAK COMPANY | 21 | ±0 | Laggard | to profit↑ | +18% | +610 bps | 81 | 2026-08-04 |
| MYGN | Myriad Genetics Inc | 21 | ±0 | Laggard | loss narrowed 87% | -11% | +3788 bps | 16 | 2026-07-31 |
| NAII | Natural Alternatives International Inc. | 21 | -1 | Laggard | loss widened 95%↓ | +23% | +206 bps | 21 | 2026-05-19 |
| SCLX | Scilex Holding Company Common Stock | 21 | ±0 | Laggard | loss widened 124%↑ | -23% | <-10,000 bps | 11 | 2026-08-14 |
| SER | Serina Therapeutics, Inc. | 21 | ±0 | Laggard | loss narrowed 17%↑ | -100% | — | 93 | 2026-08-13 |
| SOLV | Solventum Corporation | 21 | ±0 | Laggard | +4% | +2%↑ | +1573 bps | 82 | 2026-08-05 |
| TENX | Tenax Therapeutics, Inc. | 21 | ±0 | Laggard | loss widened 30% | — | — | 2 | 2026-07-31 |
| TXG | 10x Genomics, Inc. Class A Common StockGenomics & Precision-Medicine Tools | 21 | ±0 | Laggard | to loss↓ | -13%↓ | +127 bps | 99 | 2026-08-07 |
| ANVS | Annovis Bio, Inc. | 20 | -1 | Laggard | loss widened 25% | — | — | 9 | 2026-08-14 |
| APD | Air Products & Chemicals, Inc. | 20 | -1 | Laggard | to loss | +5% | -1740 bps | 58 | 2026-07-30 |
| CCEL | Cryo-Cell International Inc. | 20 | ±0 | Laggard | +75%↑ | -2% | -1226 bps | 82 | 2026-07-15 |
| HIND | Vyome Holdings, Inc. Common Stock | 20 | ±0 | Laggard | loss narrowed 96% | -98% | — | 27 | 2026-08-12 |
| MRK | Merck & Co., Inc.Obesity & Weight-Loss Therapeutics | 20 | ±0 | Laggard | to loss | +5% | -2119 bps | 79 | 2026-08-07 |
| PBYI | PUMA BIOTECHNOLOGY INC | 20 | -1 | Laggard | +33% | +8% | -619 bps | 91 | 2026-08-06 |
| SGRY | Surgery Partners, Inc. Common Stock | 20 | ±0 | Laggard | loss widened 500%↓ | +3% | +23 bps | 57 | 2026-08-10 |
| SOLS | Solstice Advanced Materials Inc. Common Stock | 20 | -1 | Laggard | -60% | +3% | — | 27 | 2026-07-30 |
| TRMB | Trimble Inc. Common Stock | 20 | ±0 | Laggard | to loss↓ | +11% | +258 bps | 30 | 2026-08-12 |
| AZTR | Azitra Inc | 19 | ±0 | Laggard | loss narrowed 6%↑ | — | — | 41 | 2026-08-12 |
| BRKR | Bruker Corporation | 19 | ±0 | Laggard | to loss↓ | +5%↑ | -622 bps | 89 | 2026-08-05 |
| CBT | Cabot Corporation | 19 | -1 | Laggard | -94%↓ | +6%↑ | -305 bps | 70 | 2026-08-04 |
| GILD | Gilead Sciences IncHuman Therapeutics | 19 | ±0 | Laggard | to loss | +10% | -3609 bps | 48 | 2026-08-06 |
| IPHA | Innate Pharma S.A. ADS | 19 | -1 | Laggard | loss narrowed 10% | -78% | — | 76 | 2026-04-01 |
| NEOG | Neogen Corp | 19 | ±0 | Laggard | — | — | +4162 bps | 73 | 2026-07-30 |
| SCL | Stepan Co. | 19 | ±0 | Laggard | +100% | +15% | -263 bps | 84 | 2026-08-05 |
| TNGX | Tango Therapeutics, Inc. | 19 | ±0 | Laggard | loss widened 6%↓ | -100% | >+10,000 bps | 86 | 2026-08-11 |
| VYGR | Voyager Therapeutics, Inc. Common Stock | 19 | ±0 | Laggard | loss narrowed 30% | -39% | -5028 bps | 16 | 2026-08-06 |
| CTKB | Cytek Biosciences, Inc. Common Stock | 18 | ±0 | Laggard | loss widened 125% | +6%↓ | -790 bps | 62 | 2026-08-05 |
| FOCL | EDAP TMS S.A. American Depositary Shares | 18 | -1 | Laggard | loss widened 53% | +2% | — | — | 2026-08-14 |
| FTRE | Fortrea Holdings Inc. Common Stock | 18 | ±0 | Laggard | loss narrowed 97%↑ | -5% | +3340 bps | 95 | 2026-07-29 |
| FTV | Fortive Corporation | 18 | ±0 | Laggard | -12% | +8%↑ | -114 bps | 45 | 2026-07-29 |
| IMNN | Imunon, Inc. Common Stock | 18 | -1 | Laggard | loss narrowed 75%↑ | 0% | — | 9 | 2026-08-11 |
| MTX | Minerals Technologies Inc | 18 | ±0 | Laggard | to loss | +4% | -498 bps | 52 | 2026-07-31 |
| TBPH | Theravance Biopharma, Inc. | 18 | -1 | Laggard | to loss↓ | -21%↓ | +4415 bps | 77 | 2026-08-11 |
| XCUR | Exicure, Inc. Common Stock | 18 | -1 | Laggard | loss narrowed 56% | — | — | 6 | 2026-08-14 |
| ACHC | Acadia Healthcare Company, Inc. | 17 | ±0 | Laggard | -44% | +8%↑ | -3982 bps | 74 | 2026-07-28 |
| AIM | AIM ImmunoTech Inc. | 17 | ±0 | Laggard | loss narrowed 88%↑ | +4% | — | 6 | 2026-08-07 |
| ARTV | Artiva Biotherapeutics, Inc. Common Stock | 17 | ±0 | Laggard | loss narrowed 28%↑ | — | — | 89 | 2026-08-06 |
| BIIB | Biogen Inc. Common StockHuman Therapeutics | 17 | -1 | Laggard | +31% | +2% | -152 bps | 66 | 2026-07-29 |
| BTMD | Biote Corp. Class A Common Stock | 17 | -1 | Laggard | to loss↓ | -9%↓ | -975 bps | 23 | 2026-08-07 |
| CMPX | Compass Therapeutics, Inc. Common Stock | 17 | ±0 | Laggard | loss narrowed 7%↓ | — | — | 7 | 2026-08-06 |
| COTY | COTY INC | 17 | +4 | Laggard | loss widened 100% | +1% | -549 bps | 66 | 2026-08-20 |
| ENVB | Enveric Biosciences, Inc. Common Stock | 17 | -1 | Laggard | loss narrowed 22%↑ | -7% | — | 21 | 2026-08-14 |
| HSCS | HeartSciences Inc. Common Stock | 17 | -1 | Laggard | loss narrowed 75%↑ | — | — | 87 | 2026-07-23 |
| MBIO | Mustang Bio, Inc. | 17 | ±0 | Laggard | loss narrowed 16% | — | — | 11 | 2026-08-05 |
| RVP | Retractable Technologies, Inc | 17 | ±0 | Laggard | to profit↑ | -31%↓ | -882 bps | 44 | 2026-08-14 |
| SLDB | Solid Biosciences Inc. Common Stock | 17 | ±0 | Laggard | loss narrowed 10% | -100% | — | 72 | 2026-08-06 |
| UTMD | Utah Medical Products Inc | 17 | -1 | Laggard | -11% | -14%↓ | -408 bps | 62 | 2026-08-12 |
| BMI | Badger Meter, Inc. | 16 | ±0 | Laggard | -13% | -7% | -135 bps | 31 | 2026-07-23 |
| ELTX | Elicio Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | loss narrowed 35% | -100% | — | 3 | 2026-08-13 |
| FULC | Fulcrum Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | loss widened 21% | — | — | 10 | 2026-07-30 |
| ICL | ICL Group Ltd. | 16 | -1 | Laggard | -44% | +5% | -322 bps | 63 | 2026-03-11 |
| INMD | InMode Ltd. Ordinary Shares | 16 | ±0 | Laggard | -36% | -6% | -546 bps | 66 | 2026-02-10 |
| ITOC | iTonic Holdings Ltd Class A Ordinary Shares | 16 | -1 | Laggard | loss widened 512% | +17% | — | 36 | 2026-03-30 |
| KPTI | Karyopharm Therapeutics Inc. | 16 | -1 | Laggard | loss narrowed 46% | -12% | +2776 bps | 3 | 2026-08-13 |
| LRMR | Larimar Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | loss widened 154% | — | — | 19 | 2026-08-04 |
| MNPR | Monopar Therapeutics Inc. Common Stock | 16 | ±0 | Laggard | loss widened 77%↓ | — | — | 96 | 2026-08-12 |
| OSUR | OraSure Technologies Inc | 16 | ±0 | Laggard | to profit↑ | -2%↑ | -894 bps | 52 | 2026-08-07 |
| WLK | Westlake Corporation | 16 | -1 | Laggard | to profit↑ | +11%↑ | -1192 bps | 16 | 2026-08-05 |
| BYAH | Park Ha Biological Technology Co., Ltd. Ordinary Shares | 15 | -1 | Laggard | to loss | +6% | — | 4 | 2026-03-02 |
| COGT | Cogent Biosciences, Inc. Common Stock | 15 | -1 | Laggard | loss narrowed 2%↑ | -100% | — | 42 | 2026-08-10 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc.Obesity & Weight-Loss Therapeutics | 15 | ±0 | Laggard | loss widened 26% | -100% | — | 25 | 2026-08-06 |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | 15 | ±0 | Laggard | loss narrowed 0% | -100% | — | 46 | 2026-07-30 |
| CUPR | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | 15 | ±0 | Laggard | loss widened 165% | +3% | — | 41 | 2026-04-27 |
| FLGT | Fulgent Genetics, Inc. Common Stock | 15 | ±0 | Laggard | loss widened 69%↑ | +4% | -1377 bps | 87 | 2026-07-30 |
| HRTX | Heron Therapeutics, Inc. | 15 | ±0 | Laggard | loss widened 50% | +1% | -801 bps | 6 | 2026-08-10 |
| SLSN | Solesence, Inc. Common Stock | 15 | -14 | Laggard | -100% | -25%↓ | -1010 bps | 25 | 2026-08-19 |
| TRAW | Traws Pharma, Inc. Common Stock | 15 | -1 | Laggard | loss widened 45% | -100% | — | 5 | 2026-08-14 |
| WHWK | Whitehawk Therapeutics, Inc. Common Stock | 15 | ±0 | Laggard | loss narrowed 74% | — | — | 52 | 2026-08-06 |
| ASIX | AdvanSix Inc. | 14 | -1 | Laggard | -90%↑ | +3%↓ | -641 bps | 38 | 2026-08-07 |
| AVTR | Avantor, Inc. | 14 | -1 | Laggard | -33%↑ | 0%↑ | -2073 bps | 95 | 2026-07-29 |
| IMNM | Immunome, Inc. | 14 | ±0 | Laggard | loss widened 30%↓ | -100% | — | 71 | 2026-08-11 |
| INBX | Inhibrx Biosciences, Inc. Common Stock | 14 | ±0 | Laggard | loss widened 26%↓ | -100% | — | 91 | 2026-08-13 |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | 14 | +6 | Laggard | -37%↑ | -23%↑ | -200 bps | 75 | 2026-08-27 |
| MDWD | MediWound Ltd. | 14 | ±0 | Laggard | loss widened 81% | +13% | <-10,000 bps | 25 | 2026-03-05 |
| MEOH | Methanex Corp | 14 | ±0 | Laggard | -61% | -4% | +228 bps | 71 | 2026-03-05 |
| NTRB | Nutriband Inc. Common Stock | 14 | +3 | Laggard | loss narrowed 97%↑ | -30%↑ | — | 92 | new filing |
| NXL | Nexalin Technology, Inc. Common Stock | 14 | -1 | Laggard | loss widened 10%↓ | -83%↓ | — | 7 | 2026-08-12 |
| OEC | Orion S.A. | 14 | ±0 | Laggard | -81%↑ | +7%↑ | -406 bps | 78 | 2026-08-05 |
| PFE | Pfizer Inc.Obesity & Weight-Loss TherapeuticsHuman Therapeutics | 14 | -1 | Laggard | to loss | +3% | -990 bps | 51 | 2026-08-04 |
| SKIN | SkinHealth Systems Inc. Class A Common Stock | 14 | -1 | Laggard | to loss | -8%↓ | +1251 bps | 14 | 2026-08-06 |
| ZBIO | Zenas BioPharma, Inc. Common Stock | 14 | ±0 | Laggard | loss widened 42%↑ | — | — | 77 | 2026-08-13 |
| ZJYL | JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | 14 | -1 | Laggard | -50% | -12% | -1254 bps | 20 | 2026-02-10 |
| ZNTL | Zentalis Pharmaceuticals, Inc. Common Stock | 14 | ±0 | Laggard | loss widened 59%↓ | -100% | — | 76 | 2026-08-06 |
| BDX | Becton, Dickinson and Co. | 13 | ±0 | Laggard | -31% | -10% | -208 bps | 61 | 2026-08-06 |
| CYH | Community Health Systems, Inc. | 13 | ±0 | Laggard | -76% | -10%↓ | +449 bps | 36 | 2026-07-23 |
| MGX | Metagenomi Therapeutics, Inc. Common Stock | 13 | ±0 | Laggard | loss widened 35% | -70%↓ | — | 19 | 2026-08-10 |
| NRIX | Nurix Therapeutics, Inc. Common stock | 13 | ±0 | Laggard | loss widened 56%↓ | -79%↓ | <-10,000 bps | 93 | 2026-07-09 |
| NTHI | NeOnc Technologies Holdings, Inc. Common Stock | 13 | ±0 | Laggard | loss widened 93% | — | — | 7 | 2026-08-10 |
| RMTI | Rockwell Medical, Inc. (DE) Common Stock | 13 | ±0 | Laggard | loss widened 570%↓ | +11%↑ | -505 bps | 35 | 2026-08-13 |
| SMMT | Summit Therapeutics Inc. Common Stock | 13 | -1 | Laggard | loss narrowed 63%↑ | — | — | 58 | 2026-07-23 |
| TSHA | Taysha Gene Therapies, Inc. Common Stock | 13 | ±0 | Laggard | loss widened 44% | -100% | — | 68 | 2026-08-11 |
| USNA | USANA Health Sciences Inc | 13 | ±0 | Laggard | to loss | -5%↓ | -637 bps | 30 | 2026-08-13 |
| ABCL | AbCellera Biologics Inc. Common SharesGenomics & Precision-Medicine Tools | 12 | -1 | Laggard | loss widened 50%↓ | -76%↓ | >+10,000 bps | 98 | 2026-08-05 |
| ADUR | Aduro Clean Technologies Inc. Common Stock | 12 | -1 | Laggard | loss widened 23% | -31% | — | 65 | 2026-08-31 |
| BMRA | BIOMERICA INC | 12 | +9 | Laggard | loss narrowed 79%↑ | +17%↑ | — | 64 | 2026-08-31 |
| CADL | Candel Therapeutics, Inc. Common Stock | 12 | ±0 | Laggard | loss widened 478%↓ | 0% | — | 97 | 2026-08-13 |
| CAPR | Capricor Therapeutics IncHuman Therapeutics | 12 | ±0 | Laggard | loss widened 23% | -8% | — | 4 | 2026-08-14 |
| CTSO | Cytosorbents Corp. | 12 | ±0 | Laggard | to loss↓ | 0%↓ | +1180 bps | 8 | 2026-08-06 |
| EMBC | Embecta Corp. Common Stock | 12 | ±0 | Laggard | -54% | -8% | +273 bps | 11 | 2026-08-07 |
| LEGN | Legend Biotech Corporation American Depositary SharesHuman Therapeutics | 12 | -1 | Laggard | to loss | — | — | 42 | 2026-03-10 |
| OBIO | Orchestra BioMed Holdings, Inc. Ordinary Shares | 12 | ±0 | Laggard | loss narrowed 24%↓ | -89%↓ | — | 80 | 2026-08-10 |
| RVMD | Revolution Medicines, Inc. Common StockHuman Therapeutics | 12 | ±0 | Laggard | loss widened 134%↓ | — | — | 96 | 2026-08-05 |
| AHCO | AdaptHealth Corp. Common Stock | 11 | ±0 | Laggard | to loss | -8% | -1259 bps | 13 | 2026-08-04 |
| BDTX | Black Diamond Therapeutics, Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 11% | — | — | 33 | 2026-08-05 |
| CC | The Chemours Company | 11 | ±0 | Laggard | loss narrowed 28% | -1% | +370 bps | 30 | 2026-08-05 |
| FEIM | Frequency Electronics, Inc.Space Economy | 11 | ±0 | Laggard | to loss↓ | — | — | 65 | 2026-07-17 |
| MOS | The Mosaic Company | 11 | ±0 | Laggard | to loss↑ | -6% | -848 bps | 33 | 2026-08-05 |
| POAS | Phaos Technology Holdings (Cayman) Limited | 11 | +7 | Laggard | loss widened 31% | -21% | — | 2 | 2026-08-31 |
| XAIR | Beyond Air, Inc. Common Stock | 11 | ±0 | Laggard | loss widened 619% | 0% | — | 3 | 2026-08-13 |
| ABVX | Abivax SA American Depositary Shares | 10 | ±0 | Laggard | loss widened 81% | -90% | — | 54 | 2026-03-23 |
| AEHR | Aehr Test SystemsSemiconductors & Equipment | 10 | -1 | Laggard | to profit | +34% | -1867 bps | 97 | 2026-07-27 |
| AKBA | Akebia Therapeutics, Inc. | 10 | ±0 | Laggard | to loss | -21%↓ | -729 bps | 17 | 2026-08-05 |
| BNTX | BioNTech SE American Depositary Share | 10 | ±0 | Laggard | loss widened 70% | +4% | -118 bps | 59 | 2026-08-04 |
| CLDX | Celldex Therapeutics, Inc | 10 | -1 | Laggard | loss widened 11%↑ | -97% | — | 76 | 2026-08-06 |
| DNA | Ginkgo Bioworks Holdings, Inc. | 10 | ±0 | Laggard | loss narrowed 32% | -59% | <-10,000 bps | 48 | 2026-08-06 |
| EYPT | EyePoint, Inc. Common Stock | 10 | -1 | Laggard | loss widened 28% | -90% | — | 5 | 2026-08-05 |
| FSI | Flexible Solutions International, Inc. | 10 | -1 | Laggard | to loss | -33% | -1961 bps | 45 | 2026-08-14 |
| GEOS | Geospace Technologies Corporation Common Stock | 10 | ±0 | Laggard | to loss | -36% | -4387 bps | 8 | 2026-08-07 |
| MOLN | Molecular Partners AG American Depositary Shares | 10 | ±0 | Laggard | loss widened 4% | -100% | — | 35 | 2026-03-12 |
| PRAX | Praxis Precision Medicines, Inc. Common StockHuman Therapeutics | 10 | ±0 | Laggard | loss narrowed 13%↑ | -100% | — | 68 | 2026-08-06 |
| SYPR | Sypris Solutions Inc | 10 | ±0 | Laggard | loss widened 56% | -3% | -1076 bps | 11 | 2026-08-18 |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | 10 | ±0 | Laggard | to loss↓ | -1%↓ | — | 73 | 2026-07-29 |
| TIL | Instil Bio, Inc. Common Stock | 10 | ±0 | Laggard | loss narrowed 81% | — | — | 27 | 2026-08-13 |
| XENE | Xenon Pharmaceuticals IncHuman Therapeutics | 10 | ±0 | Laggard | loss widened 4%↑ | — | — | 48 | 2026-08-06 |
| XNCR | Xencor, Inc. | 10 | ±0 | Laggard | loss narrowed 29% | +17% | <-10,000 bps | 96 | 2026-08-05 |
| CRVO | CervoMed Inc. Common Stock | 9 | ±0 | Laggard | loss narrowed 9% | -100% | — | 12 | 2026-08-07 |
| DNTH | Dianthus Therapeutics, Inc. Common Stock | 9 | -1 | Laggard | loss widened 2%↑ | -79%↑ | — | 75 | 2026-08-04 |
| EPC | Edgewell Personal Care Company | 9 | ±0 | Laggard | -53%↑ | -9%↑ | -753 bps | 85 | 2026-08-05 |
| HBIO | Harvard Bioscience Inc | 9 | ±0 | Laggard | loss widened 999% | +11% | +5871 bps | 92 | 2026-08-11 |
| MDAI | Spectral AI, Inc. Class A Common Stock | 9 | -1 | Laggard | loss narrowed 58% | -30%↑ | -5896 bps | 67 | 2026-08-11 |
| SVRA | Savara Inc. | 9 | ±0 | Laggard | loss widened 14% | -100% | — | 44 | 2026-08-11 |
| VBIO | Valion Bio, Inc. Common Stock | 9 | ±0 | Laggard | loss narrowed 1%↓ | +16%↑ | — | — | 2026-08-14 |
| AVD | American Vanguard Corporation | 8 | ±0 | Laggard | loss widened 999%↓ | -10% | +1335 bps | 11 | 2026-08-10 |
| FEED | ENvue Medical, Inc. Common Stock | 8 | ±0 | Laggard | loss widened 92% | -52%↓ | — | 3 | 2026-08-17 |
| LITS | Lite Strategy, Inc. Common Stock | 8 | ±0 | Laggard | loss widened 69% | — | — | 37 | 2026-05-13 |
| ORKA | Oruka Therapeutics, Inc. Common StockHuman Therapeutics | 8 | ±0 | Laggard | loss widened 156%↑ | — | — | 98 | 2026-08-10 |
| QDEL | QuidelOrtho Corporation Common Stock | 8 | ±0 | Laggard | loss narrowed 64% | +3% | -2232 bps | 17 | 2026-08-07 |
| SILO | Silo Pharma, Inc. Common Stock | 8 | ±0 | Laggard | loss widened 300%↓ | -100% | — | 7 | 2026-08-13 |
| TANH | Tantech Holdings Ltd. Class A Common Shares | 8 | ±0 | Laggard | loss widened 78% | -11% | -4110 bps | 9 | 2026-05-14 |
| TRDA | Entrada Therapeutics, Inc. Common Stock | 8 | ±0 | Laggard | loss narrowed 3%↑ | -54%↑ | — | 9 | 2026-08-05 |
| VERU | Veru Inc. | 8 | -1 | Laggard | loss narrowed 40%↑ | -100% | — | 47 | 2026-08-10 |
| VKTX | Viking Therapeutics, IncObesity & Weight-Loss TherapeuticsHuman Therapeutics | 8 | ±0 | Laggard | loss widened 90%↑ | — | — | 36 | 2026-07-29 |
| XTNT | Xtant Medical Holdings, Inc. | 8 | ±0 | Laggard | to loss↓ | -35% | -960 bps | 11 | 2026-08-11 |
| CTMX | CytomX Therapeutics, Inc. | 7 | ±0 | Laggard | to loss↑ | -92% | <-10,000 bps | 18 | 2026-08-06 |
| DCGO | DocGo Inc. Common Stock | 7 | -1 | Laggard | loss widened 45%↑ | -9%↑ | -5555 bps | 12 | 2026-08-17 |
| HUN | Huntsman Corporation | 7 | ±0 | Laggard | loss widened 933% | +1% | -424 bps | 27 | 2026-07-31 |
| KROS | Keros Therapeutics, Inc. Common Stock | 7 | ±0 | Laggard | loss widened 91% | -100%↓ | <-10,000 bps | 47 | 2026-08-03 |
| MDXG | MiMedx Group, Inc | 7 | ±0 | Laggard | to loss↓ | -35%↓ | -931 bps | 51 | 2026-07-29 |
| MLAB | Mesa Laboratories Inc | 7 | ±0 | Laggard | — | — | +88 bps | 91 | 2026-08-10 |
| NVAX | Novavax Inc | 7 | ±0 | Laggard | to loss↓ | -76% | -8914 bps | 32 | 2026-08-06 |
| VALN | Valneva SE American Depositary Shares | 7 | -1 | Laggard | loss widened 16% | -10% | -5484 bps | 13 | 2026-03-17 |
| VNDA | Vanda Pharmaceuticals Inc. | 7 | -1 | Laggard | loss widened 126% | -4%↓ | -3652 bps | 11 | 2026-08-06 |
| ATRA | Atara Biotherapeutics, Inc | 6 | ±0 | Laggard | to loss↓ | -96% | — | 92 | 2026-08-12 |
| CELZ | Creative Medical Technology Holdings, Inc. Common Stock | 6 | ±0 | Laggard | loss narrowed 15% | — | — | 10 | 2026-08-07 |
| CTXR | Citius Pharmaceuticals Inc. Common | 6 | -1 | Laggard | loss narrowed 57% | — | — | 15 | 2026-08-14 |
| LFMD | LifeMD, Inc. Common Stock | 6 | ±0 | Laggard | loss widened 220% | -25% | -1344 bps | 22 | 2026-08-05 |
| NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | 6 | -1 | Laggard | loss widened 247%↓ | -81% | — | 18 | 2026-08-05 |
| NKTR | Nektar Therapeutics | 6 | -1 | Laggard | loss narrowed 58%↑ | -9% | <-10,000 bps | 44 | 2026-08-14 |
| PMCB | PharmaCyte Biotech, Inc. Common Stock | 6 | ±0 | Laggard | to loss | — | — | 16 | 2026-07-29 |
| QCLS | Q/C Technologies, Inc. Common Stock | 6 | ±0 | Laggard | loss widened 339% | -100% | — | 8 | 2026-08-12 |
| SDEV | Stablecoin Development Corporation | 6 | ±0 | Laggard | loss widened 300% | — | — | — | 2026-07-30 |
| YARW | Yarrow Bioscience, Inc. Common Stock | 6 | -1 | Laggard | loss widened 999% | +41%↑ | — | — | 2026-08-13 |
| ALMS | Alumis Inc. Common Stock | 5 | ±0 | Laggard | to loss | -38%↑ | — | 7 | 2026-08-13 |
| ARAY | Accuray Incorporated | 5 | -2 | Laggard | loss widened 800%↓ | -7% | -137 bps | 11 | 2026-08-27 |
| AYTU | AYTU BioPharma, Inc. Common Stock | 5 | ±0 | Laggard | to loss↓ | -33% | -2122 bps | 25 | 2026-05-13 |
| GPRO | GoPro, Inc. | 5 | ±0 | Laggard | loss widened 200%↓ | -31%↓ | -693 bps | 95 | 2026-08-10 |
| IRD | Opus Genetics, Inc. Common Stock | 5 | ±0 | Laggard | loss widened 17% | -74%↓ | — | 76 | 2026-08-06 |
| NERV | Minerva Neurosciences, Inc | 5 | -1 | Laggard | loss narrowed 67%↑ | — | — | 12 | 2026-08-07 |
| NGNE | Neurogene, Inc. Common Stock | 5 | -1 | Laggard | loss widened 46%↓ | — | — | 92 | 2026-08-11 |
| OGEN | Oragenics Inc. | 5 | -1 | Laggard | loss narrowed 82% | — | — | 12 | 2026-08-13 |
| PCSA | Processa Pharmaceuticals, Inc. Common | 5 | ±0 | Laggard | loss widened 376% | — | — | 15 | 2026-08-14 |
| PRGO | PERRIGO COMPANY PLC | 5 | ±0 | Laggard | to profit | -3% | -4435 bps | 87 | 2026-08-05 |
| SIGA | SIGA Technologies Inc. | 5 | -1 | Laggard | -65% | -49% | -7701 bps | 12 | 2026-08-06 |
| TRLV | Trulieve Cannabis Corp. | 5 | ±0 | Laggard | loss widened 999% | -10%↓ | -3176 bps | — | 2026-08-07 |
| UNCY | Unicycive Therapeutics, Inc. Common Stock | 5 | ±0 | Laggard | loss widened 198% | -29% | — | 22 | 2026-08-12 |
| VRAX | Virax Biolabs Group Limited Ordinary Shares | 5 | ±0 | Laggard | loss narrowed 52% | -96% | — | 12 | 2026-07-06 |
| XBIT | XBiotech Inc | 5 | ±0 | Laggard | loss widened 267% | -100% | — | 39 | 2026-08-13 |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | 4 | ±0 | Laggard | to loss | -39% | <-10,000 bps | 8 | 2026-04-24 |
| BON | Bon Natural Life Limited Class A Ordinary Shares | 4 | ±0 | Laggard | to loss | -22% | -1655 bps | 23 | 2026-01-23 |
| DAIO | Data I/O Corp | 4 | ±0 | Laggard | loss widened 112% | -13% | -3121 bps | 49 | 2026-08-14 |
| DOW | Dow Inc. | 4 | ±0 | Laggard | loss widened 68% | -6% | -714 bps | 32 | 2026-07-24 |
| EDSA | Edesa Biotech, Inc. Common Shares | 4 | ±0 | Laggard | loss widened 140%↓ | -100% | — | 19 | 2026-08-13 |
| GLUE | Monte Rosa Therapeutics, Inc. Common Stock | 4 | ±0 | Laggard | loss widened 187% | -61%↑ | <-10,000 bps | 29 | 2026-08-06 |
| MTNB | Matinas BioPharma Holdings, Inc. | 4 | ±0 | Laggard | loss narrowed 80% | — | — | 6 | 2026-08-13 |
| OLN | Olin Corp. | 4 | ±0 | Laggard | loss widened 999% | -1% | -370 bps | 20 | 2026-07-31 |
| PVLA | Palvella Therapeutics, Inc. Common Stock | 4 | ±0 | Laggard | loss widened 77%↓ | -100% | — | 60 | 2026-08-04 |
| SPRO | Spero Therapeutics, Inc. Common Stock | 4 | ±0 | Laggard | loss widened 433%↓ | — | — | 8 | 2026-08-12 |
| AMIX | Autonomix Medical, Inc. Common Stock | 3 | ±0 | Laggard | loss widened 369% | — | — | 11 | 2026-08-13 |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 3 | ±0 | Laggard | loss widened 147%↓ | -90% | <-10,000 bps | 95 | 2026-08-06 |
| CPIX | Cumberland Pharmaceuticals Inc | 3 | ±0 | Laggard | loss widened 480%↓ | -19% | -1701 bps | 97 | 2026-08-07 |
| CRIS | Curis Inc | 3 | ±0 | Laggard | loss widened 491%↓ | -100% | — | 2 | 2026-08-14 |
| FMC | FMC Corporation | 3 | ±0 | Laggard | to loss↑ | -17% | -7536 bps | 30 | 2026-07-30 |
| MIND | MIND Technology, Inc. Common Stock (DE) | 3 | -3 | Laggard | — | -59% | -1638 bps | 9 | new filing |
| ORGO | Organogenesis Holdings Inc. Class A Common Stock | 3 | ±0 | Laggard | loss widened 670%↓ | -57% | -252 bps | 12 | 2026-08-06 |
| SRTS | Sensus Healthcare, Inc | 3 | ±0 | Laggard | loss widened 783% | -69% | -7208 bps | 22 | 2026-08-14 |
| SXTC | China SXT Pharmaceuticals, Inc. Class A Ordinary Shares | 3 | ±0 | Laggard | loss widened 293% | -35% | — | — | 2026-07-01 |
| TCRT | Alaunos Therapeutics, Inc. Common Stock | 3 | ±0 | Laggard | loss narrowed 35% | — | — | 9 | 2026-08-14 |
| ASTC | Astrotech Corporation (DE) Common Stock | 2 | ±0 | Laggard | loss widened 3% | -36% | — | — | 2026-05-13 |
| BGLC | BioNexus Gene Lab Corp Common stock | 2 | ±0 | Laggard | loss narrowed 66% | -97% | — | 13 | 2026-08-14 |
| BOLT | Bolt Biotherapeutics, Inc. Common Stock | 2 | ±0 | Laggard | loss widened 2%↑ | -100%↓ | — | 37 | 2026-08-11 |
| CATX | Perspective Therapeutics, Inc. | 2 | ±0 | Laggard | loss narrowed 24% | -72%↑ | — | 11 | 2026-08-10 |
| CELU | Celularity Inc. Class A Common Stock | 2 | ±0 | Laggard | loss widened 47% | -77% | <-10,000 bps | 65 | 2026-04-30 |
| CNEY | CN Energy Group Inc. Class A Ordinary Shares | 2 | ±0 | Laggard | loss narrowed 79% | -30% | — | 14 | 2026-01-30 |
| DCOY | Decoy Therapeutics Inc. Common Stock | 2 | ±0 | Laggard | loss widened 891% | — | — | 6 | 2026-08-12 |
| KALA | KALA BIO, Inc. Common Stock | 2 | -40 | Laggard | loss widened 999%↓ | -100%↓ | — | 1 | 2026-08-19 |
| MBRX | Moleculin Biotech, Inc. | 2 | ±0 | Laggard | loss widened 22%↑ | — | — | 8 | 2026-08-13 |
| NXTC | NextCure, Inc. Common Stock | 2 | ±0 | Laggard | loss narrowed 75% | -100% | — | 11 | 2026-08-06 |
| STRO | Sutro Biopharma, Inc. | 2 | ±0 | Laggard | loss widened 999% | -85% | <-10,000 bps | 20 | 2026-08-12 |
| AEMD | AETHLON MEDICAL INC | 1 | ±0 | Laggard | loss widened 373% | -100% | — | 3 | 2026-08-13 |
| APVO | Aptevo Therapeutics Inc | 1 | ±0 | Laggard | loss narrowed 37% | -100% | — | 8 | 2026-08-14 |
| ATPC | Agape ATP Corporation Common Stock | 1 | ±0 | Laggard | to profit↑ | -97%↓ | — | 12 | 2026-08-14 |
| CANF | Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares | 1 | ±0 | Laggard | to loss | -40% | — | 11 | 2026-03-26 |
| CNSY | Cerenome, Inc. Common Stock | 1 | — | Laggard | loss widened 999%↓ | -70% | — | — | 2026-08-14 |
| ELAB | PMGC Holdings Inc. Common Stock | 1 | ±0 | Laggard | loss widened 30%↑ | — | — | 2 | 2026-08-14 |
| GNPX | Genprex, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | — | — | 2 | 2026-08-14 |
| GRI | GRI Bio, Inc. Common Stock | 1 | ±0 | Laggard | loss narrowed 31% | — | — | 16 | 2026-08-14 |
| HELP | Cybin Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -100% | — | 98 | 2026-06-29 |
| IMA | ImageneBio, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 950% | — | — | 29 | 2026-08-05 |
| KYNB | Kyntra Bio, Inc. Common Stock | 1 | ±0 | Laggard | to profit | -209%↓ | — | 65 | 2026-08-13 |
| LYEL | Lyell Immunopharma, Inc. Common Stock | 1 | -1 | Laggard | loss narrowed 34%↑ | -50% | — | 10 | 2026-08-06 |
| MODD | Modular Medical, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 892% | — | — | 7 | 2026-08-14 |
| NVNO | enVVeno Medical Corporation Common Stock | 1 | ±0 | Laggard | loss widened 999%↑ | -100% | — | 41 | 2026-07-30 |
| NXTS | Nexentis Technologies Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -78% | — | 5 | 2026-08-13 |
| ONCO | Onconetix, Inc. Common Stock | 1 | ±0 | Laggard | loss narrowed 73% | -84%↓ | — | 1 | 2026-08-13 |
| PTHS | Pelthos Therapeutics Inc. | 1 | ±0 | Laggard | loss widened 23% | — | — | 34 | 2026-08-13 |
| PTN | Palatin Technologies, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 106% | -56% | — | 11 | 2026-05-13 |
| RNAC | Cartesian Therapeutics, Inc. Common Stock | 1 | ±0 | Laggard | -8%↑ | — | — | 52 | 2026-08-06 |
| SNYR | Synergy CHC Corp. Common Stock | 1 | ±0 | Laggard | to loss | -33% | -5730 bps | 2 | 2026-05-14 |
| SPRB | Spruce Biosciences, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 91%↑ | -100% | — | 30 | 2026-08-12 |
| ZYBT | Zhengye Biotechnology Holding Limited Class A Ordinary Shares | 1 | ±0 | Laggard | to loss | -35% | <-10,000 bps | — | 2026-04-28 |
| ZYME | Zymeworks Inc.Human Therapeutics | 1 | ±0 | Laggard | to loss↓ | -91%↑ | <-10,000 bps | 57 | 2026-08-06 |
Every US common stock and ADR in the universe is ranked on fundamental growth from the numbers companies actually filed with the SEC — no analyst estimates, no forward projections. TickerStance reads EDGAR XBRL company facts directly.
To qualify, a company must have at least six quarters of EPS and revenue history available and the most-recent filing must be no older than 200 days. That gate keeps the rankings grounded in current operating conditions rather than stale data.
Two growth factors are computed: recent year-over-year growth (latest quarter vs the same quarter last year) blended with a three-year trend score. Both factors are percentile-ranked universe-wide so a rank of 90 means the company grows faster than 90% of its peers, regardless of absolute size. The two factor percentiles are then combined into a single 1-99 fundamentals rank.
Operating margin is tracked as context — a company whose margins are expanding while growing revenue is a stronger story than one shrinking margins to buy growth — but margin level is not a direct rank input. Industries, sectors, and themes inherit their rank from the median of their members, so a strong cluster is one where most constituent companies score well, not just a few outliers.
The RS overlap metric shows what share of a cluster's eligible companies sit in the top relative-strength quintile (6M RS rank ≥ 80). When a fundamentally strong group also carries broad price leadership, it has both the earnings story and the institutional sponsorship — the combination that historically precedes sustained outperformance.
Every US common stock and ADR with sufficient SEC filing history gets a 1-99 fundamentals rank: EPS and revenue growth factors are computed from filed XBRL data, percentile-ranked across the universe, and blended. Ranks of 90+ are Leaders, 70-89 Strong, 30-69 Average, below 30 Laggards. Industries, sectors, and themes are then ranked by their members' median rank.
SEC EDGAR XBRL company facts — the numbers companies actually filed. No analyst estimates, no forward guidance, no third-party data vendor.
Sign-aware: a narrowed loss counts as improvement, a widened loss as deterioration, a swing to profit as a turnaround. Conventional percent math misreads losses (a loss shrinking from -$0.12 to -$0.07 is improvement, not "down 42%"), so the table says "loss narrowed 42%" instead of printing a misleading percentage.
The change in a group's median fundamentals rank versus 15 and 30 trading days ago — the classic "improving group" read. Positive means the group is gaining rank. Dashes mean the history window isn't available yet.
Once per US trading day after the close. The as-of date in the header is the snapshot date.